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This thesis describes work performed on the genetics of
resistance to the drugs sulphadiazine and pyrimethamine in the
rodent 'malaria parasite Plasmodium chabaudi.
A number of lines resistant to pyrimethamine were obtained
by direct exposure to the drug in a single step. Characteristically
these were some 20 times resistant to pyrimethamine and had an
increased dependence on FABA. Subsequent genetic analyses
showed that this class of mutant was genetically homogeneous and
that the primary resistance to pyrimethamine and the concomitant
FABA dependence were inseparable by recombination — both consistent
with a single gene model of resistance.
a number of lines resistant to sulphadiazine were obtained in
a single step either by direct exposure to the drug or following
FABA restriction. Characteristically these lines were some 4
times resistant to sulphddiazine and required a reduced FABA
growth supplement but exhibited a variable spectrum of cross-
resistance to pyrimethamine uncorrelated with their mode of
selection. A phenotypically indistinguishable example of this
type of line was also obtained following exposure to pyrime¬
thamine. Evidence from subsequent selection experiments was
taken to show that at least two types of separate heritable
change might result in the acquisition of sulphadiazine
1' G kj 1 £> ticlaiC G 0 ai-Xl GUxcLmple of one of these was later shown to
segregate in a simple mendelian fashion when crossed with a wild
line.
A number of lines were obtained by selection in two discrete
steps: either following the FABA restriction of a pyrimethamine
resistant line; or by the direct exposure of a sulphadiazine
resistant line to pyrimethamine. While these lines uere some
40 times resistant to pyrimethamine they exhibited wild type
responses to. sulphuuiazine and 1?ABA.
One such line was crossed with a wild line and two types
of non-parental clone were detected among the-products of the
cross. These resembled either the pyrimethamine resistant or
sulphadiazine resistant lines obtained by selection in a
single step. This result was consistent with a genetic
recombination event having taken place between, the genetic
elements proposed to confer resistance to either of these two
drugs. Evidence from a reconstruction experiment suggested that
the linkage between these elements was either loose or non¬
existent. \An unsuccessful attempt was mq.de to analyse this
cross in the greater precision afforded by the characterisation
of clones derived from single oocysts obtained by micro¬
dissection. ) In another cross between two single step lines
resistant to pyrimethamine and to sulphadiazine respectively
both wild type and double mutant parasites were detected among
the cross—products - thus confirming that recombination could
link these mutants to produce multiple drug resistance.
during the development of a rat-adapted line of P.chabaudi
(which was later shown to be unsuitable for use as a selective
marker) it was discovered that garnetocytogenesis was enhanced in
unadapted parasites during subsistence in rats. This led to the
substitution of rats for mice as rodent carriers of the foi—
parental mixed-blood infection prior to cyclical passage in
crosses.
Estimates of the rates of acquisition are presented for each
type of resistance in the Discussion together with a critic
appreciation of the extent to which these represent true
mutation rates.
IhSTiiOMJCTiOfj
Malarial resistance to antifolates was first reported in
the case of proguanil by Bishop and Birkett (1947) and by
Williamson, Bertram and Lourie (1947) in P.ga 11 inaceuia„
Clinical reports of proguanil resistance soon followed from
Malaya (Field and Edeson, 1949) in P. falciparum.
Pyrimethamine which was synthesised on the basis of its
structural resemblance to cyeloguanil, the active metabolite
of proguani1,was introduced, soon afterwards and almost
immediately McGregor and Smith (1952) reported a case of
apparent resistance in P.faleiparurn. By the end of the decade
clinical reports of pyrimethamine resistance had come from as
far afield as Venezuela (in P.falciparum and in P.vivax) and
Pakistan (in P.falciparum) as well as from the African continent
(in P.falciparum and in P.malariae), For references see inter—
l$$ns&cMsf
alia: Jones (1954, 1958); ^ liahim, (1962); Maberti (I960) and
for a comprehensive review, Peters (1970. ).
Hollo (1951, 1952) had forseen this resistance problem and
in a series of experiments carried out with P.ga11inaceuai and
P.berghei showed that the frequency with wiiich resistance to
pyrimethamine arose seemed to be related to the numbers of
parasites undergoing selection. Anne Bishop and. her co-workers
who pioneered much of the early work on antifolate and
sulphonamide resistance had already shown that pr oguani1 resist¬
ance in P.ga11inaceua was stable after cyclical passage (Bishop
and Birkett, 1947) and after repeated passage in the absence of
drug pressure (Bishop and MacConnachie, 1950a): and in a study
of metachloridine resistance (Bishop, 1958) she also found a
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correlation between the size of the infective inoculum and
the ease with which resistance developed, The suddenness
and stability of resistance suggested, a mutational origin,
a finding confirmed when she extended her study to cover
proguanil and pyrimethamine (Bishop, 1962), though no
correlation was found between the size of the infective
inoculum and the ease with which resistance developed to these
drugs. However, as Bishop herself pointed out, her drug test
was such that resistant parasites might not be detected until
a subsequent passage.
In addition to confirming the earlier reports that
pyrimethamine resistance was stable through multi passages in
the absence of drug pressure, Jacobs (1964) made the key
observation that his pyrimethamine resistant line had acquired
an increased growth requirement for PiLBA (para aminobenzoic
acid) a precursor in the biosynthesis of folate coenzymes - a
pathway blocked by the action of sulphonamide drugs. Morgan
(1974) found that the majority of pyrimethamine resistant lines
which she obtained by single step selection possessed this
increased PABA growth requirement. ( It is interesting and
relevant to note that the only exception to this rule was a line
which though it had also been selected by direct exposure to
pyrimethamine, appeared to be resistant to sulphadiazine.^ This
observation was consistent with those of Bishop and her co¬
workers (Bishop and MacConnachie, 1948, 1950a,b,c) who had also
pioneered the experimental study of sulphonamide resistance
again using the P.gallinaceum model. As well as showing this
resistance to be stable through cyclical passage, they showed
that sometimes it was accompanied by cross—resistance to
proguanil and indeed in one such case the primary resistance
manifested itself after the cross-resistance had been detected.
In addition Bishop and Birkett (1947) showed that continued
treatment with proguanil appeared to have superimposed cross-
resistance to sulphadiaaine on a line already resistant to
proguanil itself. (Bishop conducted her selection experiments
using the multi-passage technique with repeated bouts of drug
pressure).
Finally Hamakrishnan et al. (1956) showed that restricting
the dietary PABA intake of infected mice could lead to the
production of sulphonamide resistance in P.berghei: Jaswant
Singh et al. (1954) had already shown that a sulphadiazine
resistance line of this parasite (obtained after direct exposure
to the drug) required a lower PABA supplement than the line it
had been derived, from.
Clearly then resistance to sulphonamides and to anti—
folates was linked phenotypically by their effects on PABA
dependence. Recent studies have enabled us to trace this link
backwards to the biochemical level and it is now possible to
identify the sites of action of these two classes of drug in
pyrimidine synthesis. This pathway has been summarised in Fig.
12 and discussed in the accompanying text.
rest;
The close relationship between these two classes of drug .
K
has prompted their combined study in the present work. Their
known stability suggestive of a mutational origin and the
relative ease with which they may be obtained are also
encouraging from a genetic point of view. Indeed, WaHiker et
al. (1975) had shown that pyrimethamine resistance in P.chabaudi
appeared to be controlled, by a mendelian genetic element which
4
minerwelit free recombination with markers controlling enzyme
polymorphisms„
It was the main aim of the present study to continue
these investigations in both the cases of pyrimethamine and
sulpha&iazine resistance, paying special attention to the
responses of mutants in each category to both these drugs and
to their PABA dependences also. Thus it was felt necessary to
obtain a wide variety of mutants using the selective techniques
pioneered in these earlier studies just mentioned given
obvious logistic constraints such as the numbers of mice available.
Thus for example, some selections were conducted at various
intensities of drug pressure at various PABA regimes and with
i lamunosuppression.
At the outset however it was decided to limit bouts of
selection to the single step method favoured by Diggens (1970)
and by Morgan (1974) since this technique was thought to favour
the selection of single gene mutants. Although possibly easier
to measure the large degrees of resistance induced following
multi passage selections were suspected of being inherited by
more than 1 genetic change. Such mutations are notoriously hard
to analyse genetically even in micro-organisms more amenable to
study than Plasmodium. In addition it was considered crucial
that lines be cloned before and after selection for obvious
reasons. Having done this, mutant lines were then crossed with
sensitive lines in order to investigate the mode of inheritance.
Having established the genetic nature of a mutant line it was
then possible to superimpose further genetic changes by selection
and so on.
However such a classical approach has its inherent
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limitations and. it was felt that a more detailed analysis was
desirable than had been hitherto possible using the available
techniques. Before these are introduced, it is worth
considering the "state of the art."
The first reports of a genetic study of malaria parasites
appeared in a series of papers authored by Trembley and
Greenberg (Greenberg and Trembley, 1954a,b; Trembley and
Greenberg, 1954; Greenberg, 1956). They crossed a mild line
of j?.gallinacetun with a virulent resistant one and after joint
mosquito passage detected lion parental parasites resistant to
pyrimethamine and with a mild growth characteristic. However
as they themselves were aware (Trembley et al., 1951), this
growth characteristic was an unstable one. This and the fact
that they failed to clone their parent lines prior to the cross
renders their interpretation of their results open to question.
In another study Yoeli and his co-workers (Yoeli, Upmanis
and Most, 1959) claimed to have shown evidence of an infective
gene transfer mechanism which they christened "synpholia." They
inoculated a mouse with a mixed infection of P.vinckei parasites
which had been made resistant to pyrimethamine and a sensitive
P.berghei line. Pyrimethamine resistant P.berghei parasites
were later detected in 6 out of 12 hamsters subinoculated from
the mixed mouse infection. Without an intervening mosquito
passage there had been no opportunity for a sexual mechanism to
generate these non parental parasites so Yoeli proposed that the
transfer of genetic information had taken place during the
simultaneous invasion of red blood cells by parasites from each
of the parent lines, thus mimicing the transformational or
transductional processes known to occur in certain bacteria.
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(See Hayes 1969 for a review of tliese)^ However, no further
reports of synpholia have come from Yoeli's laboratory and
Walliker (1971, 1973, 1975) in his studies of genetic
recombination on P.yoelii and P.chabaudi was unable to find
evidence of this mechanism though he did not specifically look
for it.
The most satisfactory study of genetic recombination in
Plasmodia has been that carried out by Walliker in this
laboratory (Walliker et al, 1971, 1973, 1975, 1976) and by his
co-workers Morgan (1974); Uosario (1976a,b) and Oxbrow (1972).
These studies have all confirmed the existence of a conventional
mendelian mechanism in rodent malaria parasites leading to the
reciprocal exchange of genetic information following mixed
mosquito passage. These techniques (described elsewhere pp33"40)
were given invaluable aid and stimulus by the work of Carter in
developing electrophoretic techniques for the detection of
enzyme polymorphisms in different species of rodent plasmodia.
(Carter, 1970, 1973; Carter and Walliker, 1975). These enzyme
polymorphisms represent the best evidence of genetic variation
in malaria parasites to date as their detection is straight -
forward and their interpreation unequivocal. By using them in
genetic studies it lias been possible to demonstrate recombination
between variants of glucose phosphate isomerase and a marker
conferring pyrimethamine resistance in P.yoelii (Walliker et al,
1971, 1973). In a later study recombination was shown to have
taken place between enzyme variants themselves in Lactate
dehydrogenase (LBS) and 6 phosphogluconate dehydrogenase (6KKD)
in P.chabaudi (Walliker et at, 1975). This last must be
considered a paradigm for genetic recombination in plasmodia.
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In the same laboratory genetic studies aimed at elucidating
the inheritance of drug resistance have been carried out by
Morgan (1974) in the case of pyrimethamine resistance in P.yoelii
and by ilosario (1976a,b) in the case of chloroquine resistance in
P. eiiahaudi and in the same organism in the cases of pyrimethamine
and sulpliadiazine resistance with special reference to their
combined inheritance by the present author. The work of Morgan
may be considered of particular relevance to the present study as
she pioneered many of the techniques and approaches described
herein.
She investigated the behaviour of 2 types of marker
conferring resistance to pyrimethamine after crossing each with
a wild type line. In the first of these types of cross the
marker had been accompanied after selection by a decreased
dependence on FABA. These appeared to segregate independently
as separate mendelian factors although Morgan herself admitted
the number of cross product clones examined was too small to
permit general conclusions to be drawn from this observation.
Moreover, the character PABA dependence was not easy to
distinguish owing to the rather small differences in PABA
dependence observed between the parent lines she used. In
another cross the pyrimethamine resistance marker had been
accompanied after selection by an increased PABA dependence and
although analysis confirmed the apparent mendelian inheritance
of this type of pyrimethamine resistance, the cross product
clones were not characterised for their dependence on PABA.
In the present study screening techniques exploiting the
increased PABA dependence of some pyrimethamine resistance
mutants have been widely exploited. This adjunct to the
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characterisation of individual clones is widely used in the
genetics of other micro-organisms (see Hayes, 1969 passim) and
makes possible the detection of certain rarer genetic events
which might be missed using conventional techniques. Clearly
care has to foe exercised in the use of such techniques lest
mutants, selected ue novo, be scored as recombinants but this
danger can foe avoided by the use of appropriate controls and
by restricting numbers to submutationa1 levels; and in any case
these dangers do not apply to the interpretation of negative
results.
At the other end of the scale it was considered desirable
to perform an analysis of individual genetic events to be
revealed by the characterisation of clones derived from the
products of single hybrid oocysts harvested before rupture.
Although single oocysts were known to be infective (Walliker,
1972) there was some doubt as to the infectivity of the
individual sporozoites contained therein (Vanderberg, 1975).
In the conventional genetic analysis, clones selected at random
from among the mixed population of hybrid and non-hybrid oocyst
derived cross-product blood infections were characterised. Thus
the reciprocity of genetic exchange within oocysts could only
inferred and more direct evidence was desirable particularly in
the case of characters whose inheritance might be complex such
as drug resistance. "Proof of reciprocity demanded the analysing
of the segregation of as many character pairs as possible and
prompted one development of die rat attempted line of p.cliabaudi
(see-below). Walliker et al»(1975) had expressed the hope that
such a study would lead to the more precise location of the
meiotic reduction division in Plasmodium particularly in the
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light of a report based 011 cytologies! evidence that such a
division took place within the oocyst itself (Sinden and.
Canning, 197 8} „
Partly in order to satisfy the demand for additional
markers to be analysed by the single oocyst technique and
partly in order to provide a selective marker for screening
techniques but one unconnected with drug resistance and there¬
fore probably free from interactions with drug resistance
markers it was decided to develop a line of P.chabaudi adapted
to growth in rats. This technique had been reported before
(Coombs and Gutteridge, 1975) and it brought an unexpected but
vital bonus.
During these selection experiments it was found that non-
adapted lines of P.chabaudi produced greatly increased numbers
of gametocytes when injected into rats and that the normal
processes of exflage1lation took place subsequently (MacLeod
and Brown, 1976). This was important since P.chabaudi, although
possessing several advantages over the other rodent model used
in earlier crosses, F.yoelii was more difficult to passage
though mosquitoes and perform crosses with and these difficulties
had been, attributed to the paucity of gametocytes in P.chabaudi
infections. Consequently, the conventional crossing technique was
modified by the substitution of rats for mice as rodent carriers
of the mixed parental blood infection.
These techniques were exploited to investigate a number of
questions regarding the inheritance of resistance to sulphaciiaziiie
and pyrimethamine together with the selection experiment data.
1. Were pyrimethamine resistance and the concomitant increase
in PABA requirement pleiotropic characters of a single genetic
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change or were these inherited separately?
2. Could the above class of mutants be ascribed to changes in
the same gene locus in independently arisen examples?
8. Was resistance to sulphadiaziue inherited in a simple
mendelian fashion as had been desmonstrated in the case of
pyrimethamine resistance?
4. Did the genetic elements controlling resistance to
pyrimethamine and to sulphadiazine recoiabine freely and could
an estimate be obtained of this recombination frequency?
While it has been considered that satisfactory answers were
obtained to tnese questions, several lines of investigation were
attempted unsuccessfully. Those that failed for reasons
considered to be other than the merely technical have also been
included: e.g. the results of the attempted characterisation of
hybrid single oocysts in the section dealing with the relevant
cross which had been already performed using more conventional
techniques and the results of the cross using the rat adaptation
marker.
Finally, two assumptions underlay the interpretation of
cross results. Firstly, it was assumed that no gross distortion
in the relative frequencies of parental and recombinant classes
had taken place such as might have resulted due to mutant lines
being at a significant disadvantage over their wild counterparts
in mixed infections. Consideration of the results of Valliker
et al.(1975) when they crossed a wild and a pyrimethamine
resistant line of P.chabaudi showed no evidence of natural
selection - but this evidence was not wholly unequivocal. In an
experiment specifically designed to detect natural selection for
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or against pyrimethamine resistant lines of P.chabaudi, Hall
(unpublished results) found no evidence of gross distortion in
input frequencies folloving mixed passage though his technique
•would not have detected minor ones. Secondly, it was assumed
G ixvX G ci> G ites were haploid in respect of their genetic complement.
Both Carter (1970, 1971, 1973) and t/a lliker et al, (1971, 1973,
1975) had been unable to find an instance where a cloned
parasite exhibited more than one type of an enzyme variant either
in the case of parasites obtained from wild infections or
following a cross between parasites differing in respect of the
enzyme variant they possessed. Thus the evidence for haploidy




a* Nomenclature a,ad Provenance
Apart from one experiment using P.vinckei all the work in
this study concerns Plasmodium chabaudi.
P.chabaudi was described by Landau (1965) who isolated this
parasite from thicket rats (Thamnomys rutilans) of the Central
African Republic. The development and infection patterns of
these parasites were studied by Landau and Killick-Kendriek
(1966); Wery (1968) and by Landau-et al.(1970).
Bafort (1968) reclassified the parasite as a subspecies of
P.vinckei but following electrophoretic studies Carter and
lialliker (1975) renamed the parasite P. chabaudi on account of
its range of enzyme polymorphisms.
The parasites used in the present study were obtained from
infected blood samples obtained from thicket rats trapped in the
Central African Republic in 1969.
b. Life cycle of P.chabaudi in Mice and Mosquitoes
P.chabaudi infections in this laboratory were typically
synchronous over a 24 hour division, cycle with schizogony
occurring around midnight. SchizontS typically yielded between 4
and 8 raer oz oi t e s.
Gaiaetocyt©genesis reached its greatest intensity in mice
after the peak of the blood infection, that is about 10 days after
inoculation. However it never occurred with anything like the
intensity observed in other rodent Plasmodia such as P.yoelii or
P.vinckei in this host.
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Cyclical passagj&s were initinted by permitting mosquitoes
(iuiO£hejLeti stcphonsi) to gorge themselves on blood containing
macro - ana microgame tocytcs.
bporozoites were detectable in audi mosquitoes after about
il weeks una tUuse could then be used to initiate blood infections
by a variety of teclmi. uea described elsewhere
c. I)ef initi on of "isolate", " line" , "clone" and "stabilate"
Isolate:- a sample collected from a wild rodent or mosquito on
a single occasion unci preserver either by repeateu passage or
cryogenically. Isolates are not necessarily genetically uniform
and amy contain parasites from different species.
&tabilate;- a sample of parasites preserved in a viable
condition on a unique occasion (Lumsden ami Hardy, 10U5) such
us i oliov.'ing cryoproservati on.
Line:- in the present work tuis refers to any number of
parasites which had the same special treatments together since
their last cloning. Thus ret 1ouing or selection procedures
createn new lines but routine muintuinance did not.
Clone;- a group of parasites thought to be genetically uniform
following the asexual multiplication of a single organism. How¬
ever the random occurrence of spontaneous mutation was unavoid¬
able and given this, these mutants wore probably omnipresent.
(<.* J ii o s t ■„.> po c x o s:
a. iiouent
doth rats and mice wore used. For drug- and PABA tests,
male inbred C57 black mice (Centre for Laboratory Animals, The
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Bush, Edinburgh) were used exclusively. For cloning and routine
passage these and mixed strains obtained from the main mouse
colony of this department were used. Male inbred white rats
(liattus norvegicus) were exclusively used in rat experiments
(Obtained from "The Bush" also,)
The temperature of the mouse house was nominally 1S°-22°C
and was lit by daylight.
b. Mosquito
For cyclical transmissions Anopfaeles stephensi maintained
in this laboratory were used. These were nominally maintained
o
at 25 C at 90% humidity under artificial light conditions of
alternating 12 hours light and darkness. Mosquitoes were fed on
rabbits prior to experimental use and on a 10% solution of
glucose supplemented with PABA (0.05%) thereafter.
Stray mosquitoes were discouraged from entering the mouse
house by the use of double doors and as a last resort, by
swotting.
(^) Routine Maintenance of Parasites in the Laboratory:
a• Preservation in Liquid Mitrogen
Stabilates of infected blood were stored in sealed capillary
tubes kept in liquid nitrogen (~196°C) after the method of
Lumsden et al. (1966). When required stabilates were thawed and
after dilution in citrate saline (G.9% sodium chloride, 1.5%
sodium citrate, adjusted to pH 7.2) injected into mice intra—
peritoneally.
k• Syringe Passage
Routine blood passage was effected by tail bleeding of an
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infected rodent into a syringe containing citrate saline and
by injection of about 0.1 ml of the diluted blood into an unin¬
fected rodent.
c« Cyclicol Passage
*) Rodent to Mosquito
Routine mosquito passage was not considered necessary since
lines showed no diminution in fertility even after 50 or more
syringe passages. Cyclical passages were carried out from time
to time in order to measure fertility as well as forming a basis
control procedure in crosses.
The standard procedure involved feeding mosquitoes
(Anopheles stephensi) which had been starved for one or two days
on mice inoculated some ten days previously i.e. when the amount
of exfiageHating gasaeoocytes had reached a peak. From the
following day the mosquitoes received 10fo glucose made up in PABA
(0.5 g/l). However, the success rate of this method in
transmitting P.cliabaudi through moscmitoes was found to compare
rather unfavourably with rates of P,y,nigeriensis and IVyoelii
K
transmission. A further complication arose while attempting to
transmit virulent lines of P.chabaudi. These killed most if not
all mice before the infections contained sufficient sexually
mature parasites.
Fortunately, the discovery made while developing a rat
adapted line of P.chabaudi that a substantial proportion of
parasites injected into young splenectomised rats developed into
garnetocytes enabled these hosts to be used with more success in
transmission. (Method described fully in this Section
(pp 35 -2>~7 }.
ii) Mosquito to Rodent
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About 8 days after the blood meal a sample of around 10
mosquitoes ims dissected and oocysts were counted microscopically
as described in this section (p; IS ).
To begin with sporozoites were harvested after about 14
days from triturated salivary glands dissected into cold tissue
culture medium. (Modified Kitaiaura's medium and VP12 medium
(pudney and Varma, 1971)), Where more than about 20 mosquitoes
were being dissected, these were triturated whole after the
removal of legs and wings. The triturate was eentrifuged at
2000 EPM for 4 minutes at 4 C and the sediment discarded. Up to
0.5 nil of the sporozoite suspension was then inoculated intra¬
venously into each of a group of mice.
After April 1974 in order to maximise the number of
sporozoites contributing to the resulting mouse infection, the
"natural" method of transmission, was used in the majority of
instances. Thus infected mosquitoes were allowed to feed on mice
about 14 days after the blood meal. If need foe the process was
repeated the following night.
Mouse infections resulting from sporozoites could foe detected
some 4 to 8 days later.
(4) Counting nee. Blood Cells and Parasites:
a. lied Blood Cells
These were counted using a Coulter counter. Routinely
dilutions for counting were made with 2.' micro-litres of tail
blood injected from a micro capillary cube into 100 ml formalin^




The percentage of parasitised erythrocytes (hereafter percent
paraaitaemia) was estimated from counts performed on thin smears
Chemicals Ltd.) When accurate counts were required the sample
size was related to the limits of error deemed acceptable. When
measurement errors were required to be known these were estimated
using Eayter's formula (cited in Morgan, 1874). The relationship
between measurements of different parasitaemia levels and their
errors for different sample sizes is illustrated graphically in
When a mean of several measurements was required this was
obtained geometrically (logarithmically) and individual
measurement errors summed by the method of least squares. Errors
have therefore been expressed as geometric ranges of + 1 standard
error.
Standard Errors in parasitaemia counts (expressed as a percentage
of the measurements to which they are attached) over a range of
parasitaemia levels at their usual sample sizes:
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c* Oocysts and Sporozoites
The number of oocysts per infected gut was determined by
examination of dissected guts in coverslip preparations
magnified 400 times using a phase contrast objective.
Accurate sporozoite counts were not carried out. Their
abundance was merely noted after examination of coverslip
preparations magnified 400-1000X and viewed under phase contrast
i1lumination»
(5) Preparation of Inocula Containing KnownParasite Numbers
Except during routine serial passage, animals were
inoculated with known numbers of parasites. These ranged from
inocula containing fewer than one parasite in dilution cloning
10
up to and occasionally exceeding 10 parasites in some experiments
using rats. The volume of all inocula prepared by dilution was
-I
normally 10 ml. fthen undiluted or centrifuged infected bloods
were inoculated, the volumes of these inocula ranged up to 2 ml
in some rat experiments.
a* C ollection of Bloods
Prior to exsanguin^ation parasitaemia counts and erythrocyte
counts were performed on donor animals. When more than one donor
was required these counts were performed on the mixed bloods in
vitro. Blood was collected either from the heart or from the
brachial vessels using minimal heparin (approx. 5 iu ml *). In
some experiments requiring a large number of donors time saving-
was accomplished by a rapid accurate system of subinoculation:
thus donors were bled into microca.pillary tubes of known capacity
and each of these were then drawn into a syringe containing about
0.3 ml of heparinised serum ringer and kept on ice until
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inoculation.
b. Dilutions (including; Clonal Dilutions)
The vast majority of dilutions fell into two numerical
6 , . 8
categories: those containing between 10 and 10 parasites per
ml. e.g. in the cases of drug or PABA tests and selection ex¬
periments; and those containing fewer than one parasite ijs per
ml - mostly cloning procedures.
When accuracy was required potential donors with parasitaemias
lower than about Vf0 were rejected since these were regarded, as
being over prone to counting errors: those exceeding parasit¬
aemias of 20fi■> were also rejected since this figure represented the
approximate limit of exponential growth in P.chabaudi, However,
when cloning the upper limit was set at about 8fc to minimise the
chance of inducing infections derived from erythrocytes containing
more than one parasite.
Dilutions were effected using calibrated pipettes for
q
dilution factors not exceeding 5 x 10 per step or by using
microcapillary tubes ranging in capacity from 1 to 20 microlitres
for dilution steps exceeding that figure. Dilutions exceeding
•5
5 x 10 required more than one step. (Even in the case of clonal
dilutions most of which required two dilution steps, the limiting
factor on accuracy was that of the parasitaemia counts themselves.)
No significant difference was found in. infectivity of clonal
inocula vw cither the intravenous or the intraperitoneal routes
so the latter was used in the present study for logistic reasons.
When performing such inoculations poorly injected mice were
rejected immediately lest their inclusion among mice scored as
uninfected artificially improved the results of that cloning
experiment. Blood smears were taken of the remaining mice after
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8 days and for up to 20 days following inoculation although in
practise on only one occasion did an animal become patent after
20 days which had been ajudged clear at 16 days.
Clonings were considered successful if fewer than one in
5 mice became infected: given a Poisson distribution of
parasites among mice this figure implies that 90$ of such in¬
fections had arisen from a single parasite. Since routine in¬
fection rates following cloning were less than about 10$, the
chances of infections having arisen from more than one parasite
were proportionately diminished. On only one occasion was a
"clone" discovered to have arisen from such a multiple infection.
(However, it is worth noting that while electrophoresis of enzyme
variants during the analysis of cross—product clones made possible
the detection of "doubles" which differed in these variants, it
is unlikely they would have been spotted by drug testing alone
since drug resistance may be considered dominant over sensitivity.)
^
c* inocula Containing More Than 10 Parasites
In some experiments rats were inoculated, with large amounts
of blood typically from 0.5 to 2.0 ml. The intravenous route was
preferred for these inoculations since that method seemed to give
more predictable results and made it possible to immediately
count parasites before such possible factors as cell division or
host passive immunity might have affected their numbers.
On some occasions mouse bloods for these rat inoculations
were packed by centrifugation (lOOOg for 4 minutes): in this way
10
it was possible to inject up to 10 parasites into each rat,
resulting in instantaneous parasitaemias which typically ranged
from 15 to 30$.
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(G) The Diet of Exporimental Animals:
Routinely all the animals used in this study were maintained
on "Quayside" rat cake fed ad libitum (MacGregor's of Leith,
Scotland, ).
In one series of experiments designed to compare the
standard diet with a milk diet known to be deficient in PABA
(Hawking, 1953), mice were allowed to feed ad libitum on a dry
paste prepared from "Ostermilk" suspended in minimal tap water.
No special attempt was made in these studies to prevent
copropliagy.
Drinking water was supplemented with para-aminobenzoic acid,
hereafter PABA, (Sigma ) at 0.5 gl * unless otherwise stated.
Animals were maintained on a given PABA regime for at least seven
days prior to inoculation.
(7) The Source Preparation and Administration of Drugs:
a. Pyrime thamiae
Pyrimethamine ("Daraprim": 2, 4 diamino—5— p—clilorophenyl—
6—ethyl—pyrimidine) in the form of powdered base was obtained from
the Wellcome Research Laboratories, England, courtesy of Br. R.A.
Neal.
Drug doses were related to the mean body weight of a group
of experimental mice. Doses were calculated in mg/kgm from
weighings taken on the first day of drug administration.
A range of stock solutions of pyrimethamine in distilled
water at 0.5, 5 and 25 mg/ml were prepared according to the
method of Yoeli et al.(1969). Thus a known weight of pyrime¬
thamine powder was suspended in distilled water to which two
drops of Tween SO per 10 ml had been added. The suspension was
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sonicated in bursts for a total of b minutes using a Soniprobe
and having been made up to the required volume in a measuring
flask and transferred to a thick walled glass container for
storage. Further dilutions from the stock solutions were made
in sodium carboxymethy1 cellulose (2°/o) and shaken on a vortex
mixer immediately prior to administration. 0.1 ml aliquots of
the final drug solutions were given via the intraperitoneal
route. Routinely control mice received 0.1 ml sodium carboxy¬
me thy1 cellulose solution 2%.
b. Sulfadiazine
Sulphadiazine (2-sulphonamido-pyrimidine) in the form of
a dry powder was obtained from May & Baker Ltd., England.
Drug doses were calculated by the same method as that used
for pyrimethamine.
A range of stock solutions of Sulphadiazine between .05
and 100 mg/ml were prepared by suspending the dry powder in warm
2fo Sodium carboxymethyl cellulose. The stock suspension was
stirred magnetically before use and further dilutions were made
in 2?jo Sodium carboxymethyl cellulose and shaken on a vortex
mixer immediately prior to administration. As with pyrimethamine
0.1 ml of the final drug solution was given intraperitoneally -
the controls receiving 0.1 ml Na CM C only.
(8) Techniques for the Measurement of Variation:
a. Starch gel electrophoresis - method of Carter (1970, 1971)
i) Preparation of material:— Mice (strain immaterial) with
high blood infections (i.e. less than 20% parasitised erythrocytes)
were etherised and bled from the brachial artery into sufficient
citrate saline to make up to 10 ml in a centrifuge tube. After
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centrifugation at lOOOg for 5 minutes, the supernatant was
discarded and the packed blood cells nixed thoroughly with half
their volume of Q.l'dfo saponin in 0.85Na CI. Each sample was
O
then incubated for 20 minutes at 37 C in a shaking water bath...
Samples were then removed and after resuspension in 10 volumes
of ice-cold 0,85^ Na CI centrifuged again - this time at SOOOg
for 10 minutes at 4 C. The supernatant was then discarded and
only the upper greyish layer of parasite material retained.
Material for immediate electrophoresis was freeze thawed
twice in three times its volume of distilled water (to disrupt
the parasite membranes ).
Usually however samples were preserved and different
batches run together for reasons of economy, This meant re-
suspending the parasite material in about 1 ml of distilled
water in a bijou container. These were left overnight to freeze
in a dry ice refri#gerator. Frozen samples were then vacuum
dried in an apparatus comprising a des^siccator jar connected to
a condenser flask immersed in a dry—ice/ethanol freezing mixture
in a Dewar container. Vacuum was maintained by an electric
pump. Freeze dried samples were preserved in an evacuated
desiccator jar and kept at 20°C.
ii) Enzyme assay and electrophoresis:- P. chabaudi is poly¬
morphic for iso-enzymes of 6H5B (6 phosphogluconate dehydrogenase)
and LliH (Lactate dehydrogenase) Carter and Walliker (1975). The
basic principles of electrophoresis were of course the same for
both these enzymes but the methods in each case differed in the
specifics of buffer system, incubation system and in the
duration and intensity of electrophoresis. These details to¬
gether with the gel formula are given in Carter (1971),
Prior to electrophoresis about 1 mg of sample material was
dissolved in a droplet of distilled water delivered from a
syringe through a narrow gauge needle. Cellulose acetate strips
soaked in these samples were..then inserted into the prepared gel
with the assistance of a metal comb thus defining the origin
line at a right angle to the axis of electrophoresis.
Each gel was then placed 011 a cooling plate between two
electrode troughs each containing 500 ml of the appropriate
electrode buffer and wicks laid over the edges of' the gel so
that they would just meet the edges of the cooling plates. A
thin sheet of polythene was then laid over the gel and wicks and.
covered by a second cooling plate. The appropriate current and
voltage were then applied across the gel from a stabilised power
supply for between 3 and 14 hours - depending on the system being
used.
After switching off the power supply the cellulose acetate
strips were removed and the gel sliced horizontally. Slices
could then foe incubated with the appropriate enzyme assay
solution to reveal the positions of both host and parasite enzyme
activities.
ill) Band identification:- Isoenzyme type was norm ally
identified by comparison with samples of known identity run on
Che same gel. Since in the vast majority of cases only two
configurations were possible for each enzyme - those of the
lines Herein designated AS (LLlIi type 3, 6H>I) type 2) or AJ
(L]bH type 2, 6PGD type 3) - identification resolved itself into
questions of the type either, or. (For an explanation of iso¬
enzyme nomenclature see Carter (1974).J Identification was
further simplified in the case of L1)II since the isoenzyme
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characteristic of lines AS and AJ migrate in opposite
directions from the origin.
It. Measurement of Drug Resistance
The 4 day test developed by Thurston (1950) was routinely
used for drug testing. Groups of a 4 C57 mice, standardised
for sex (male) and age and therefore of approximately similar
weights were set up in different cages and inoculated with
parasite aliquots (routinely 10^ parasites per inoculum). Drug
dosage was based on cage weight and the appropriate amount of
drug administered via the intraperitoneal route 3 hours after
inoculation, and on each of the following 3 days at about the
same time of day. (In this study druggings were usually
carried out between 4 and 7 pm). Control cages received
injections of Sodium carboxyrnethy1 cellulose only as did PABA
test cages if they were included in theitest.
Parasite counts were made on the fourth and subsequent
days after inoculation. The geometric mean count for each
drugged group was expressed as a percentage of the control
group. These percentages were converted into logs, and plotted
against log. dose. A straight line plot was drawn between the
points spanning the line of 10% survival, and the drug dose
corresponding to the point where the plot crossed this line
(EDqq) read off. Measurement errors and within-group-variation
errors were summed by the method of least squares and the
resultant total standard error expressed as a range in the text.
(The dose required to reduce the infection to the size of
the original inoculum was estimated by extrapolation after
making the assumption that each mouse contains about 3 x 10^
red blood cells. This very roughly estimated dose (ED. . p.s. =ps
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plasmodiostatic) tos only used for guidance in planning some
selection experiments in which continuous drug pressure was to
be applied for longer than just 4 to 6 days.)
Having obtained base line ED estimates for wild type
lines. It was possible to express the increase in resistance
achieved after selection in the mutant lines derived from them.
Thus where in the text a mutant line is described as having a
pyrimethamine resistance of 20X this is a shorthand way of
saying its EDg^ for pyrimethamine is some 20 times greater than
that of the wi Id type.
When large numbers of lines were being tested simultaneously
it was logistically impossible to carry out full drug tests. In
these cases "mini" tests were carried out using only 2 control
animals and 2 drugged and sometimes 2 animals receiving a low
PABA supplement, while this had the advantage of reducing the
number of mice required by at least half, it did mean that drug
responses could only be expressed as a percentage growth
(compared with the untreated controls) rather than as an SBqq .
Data from such tests were interpretated with more caution but
with a judicious choice of dose & single dose test could be used
to detect qualitative differences in drug responses: (i.e.
growth vs no growth ), Moreover, having made due allowance for
the greater variance of these mini-tests they agreed fairly well
with the results of the full 4 day tests which were subsequently
performed on a selection of lines.
Routine quantitative 4 day tests were carried out on all
lines used in this study both as precaution against mixups and
as a check on stability. (No instances of changes in resistance
were attributed to instability in this work.)
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Finally, it is worth repeating again that all estimates of
drug response were obtained from animals fed on the standard rat
cake. As a general rule all estimates of pyrimethamine
resistance were obtained with the standard PAEA supplement of
0.5 gl and whereas this supplement was used for estimations
of sulphadiazine resistance obtained after January 1975, estimates
before this date were obtained without any such supplements.
However, there were several exceptions to this general rule and
these have been indicated in the text.
c. Measurement of the Requirement for Dietary PAISA
Supplementation
Altered requirements for PABA growth supplementation were
measured using a modification of the tests used to measure drug
responses. Since growth to a peak at a given PABA level either
did or did not occur - the alternative being no growth at all or
very rarely a low—level fleeting infection soon after inoculation
— it was decided to use a simple qualitative index of PABA
dependence: growth vs no growth (symbolised in the text as +
and - respectively ).
Groups of 2 to 4 mice, standardised for age and sex and of
similar weights were set up in different cages and maintained on
experimental PABA levels for at least a week prior to inoculation
with standard aliquots of 10^ parasites.
Parasite counts were carried out regularly and usually until
the control animals (receiving the normal PABA supplement of
0.5gl / were past peak infections. At the chosen experimental
PABA levels of 0.05 and 0.025 gl * and with no supplement at all
(zero PABA in the text) growth conformed to the either or pattern.
(Other PABA levels were abandoned due to the variable results
28
they gave.)
An added complication arose sometime between Christmas 1974
and January 1975 when all lines showed a significant increase in
their requirements for PABA supplementation. The change
occurred in all lines and. the PABA "rank order" remained un¬
changed. Drug testing ana electrophoresis confirmed no mixups
had occurred and the manufacturers denied any change in the
composition of their rat cake had taken place. Unfortunately no
samples of the old rat cake were available for comparison or
analysis. {aee ppW-% for a discussion of this phenomenon.)
PABA requirement data have therefore always been bracketed
with the period to which the tests refer. Thus the expression
that a line required zero PABA {.post Jan. 1975) is a shorthand
way of saying that the line in question required no PABA
supplement to reach peak levels of infection when tested after
the upward shift in requirements took place.
d. Determining the Ability to Grow in Eats
P.chabaudi although able to reach parasitaemias exceeding
80fo in mice infected with single parasite inocula is quickly
eliminated from intact rats. Growth in splenectonised rats
tends to be erratic and this ability diminished as the rats grow
to adulthood. Since it had been planned to use rat adaptation
as a genetic marker a simple series of growth tests was devised
to distinguish between wild and adapted parasites.
Animals used in these tests, male norway wistar rats, intact
or splenectomised, newly weaned or adult, were inoculated intra—
peritoneally with 10° parasites. Blood smears were taken and
daily parasitaemia counts estimated. Accurate counts were made
of the blood smears representing the peak of each infection and
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the group geometric means computed.
Because it almost always proved impossible to obtain more
than 8 rats standardised for age and sex comparative tests of
growth in rats used only 2 animals for each test.
(9) Selection Experiments;
a* Selection for Drug Resistance
All mice in selection experiments were inoculated intra—
peritoneally with 0.1 ml aliquots of blood parasites diluted in
citrate saline. Selection pressures were commenced so that
parasitaemias did at no time exceed 10% to minimise the risks
of subsequent immune host reaction. In computing the number of
parasites subjected to selection pressure, sample parasitaemia
counts were continued until peak infection and this value used.
Mouse blood volumes were roughly estimated on a mouse weight
basis—at a rate of 2 mis blood per lOg body weight. Mouse blood
9
was assumed to contain 8 x 10 red blood cells per ml.
Drug doses were calculated from mean cage weights and drugs
administered intraperitonea1ly from 4 to 6 days in the case of
short-term, high—dose therapy and for up to 20 days in the case
of continuous drug therapy. Thin blood smears were made 12 days
after the commencement of drugging and every 4 days subsequently.
Animals without patent infection after 20 days were considered to
be free of parasites and discarded. (Subinoculations from a small
sample of these were occasionally carried out and the results of
these seemed to bear out the last assumption.)
In the case of selection by PABA restriction tap water was
merely substituted for the normal supplement of 0.5gl~^ in the
drinking water. Otherwise selection was conducted as described
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above.
If recrudescent parasites were observed following
selection tliese were tested for the appropriate responses using
an abbreviated version of the 4 day suppressive test (Thurston,
1950), A sample of these were then tested more rigorjously,/after
cloning using the full 4 day suppressive test and their
quantitative drug responses worked out. Recrudescent parasites
reckoned to be sensitive after the preliminary tests were dis¬
carded although the possibility that they concealed resistant
parasites was not ruled out,
b. Selection for Adaptation to Growth in Rats
Newly weaned inbred male Norway rats were splenectoraised
as previously described, and inoculated intraperitoneally with
0.5 ml of blood harvested from mice at peak infection. After
10 days growth in rats bloods were harvested again and used to
infect a second group of splenectomised rats and so on until
they had undergone seven such passages. The whole process was
repeated this time using intact rats and cloned in mice. Four
mouse passages followed, the parasites being harvested after
peak infection. The line was then passaged through mosquitoes
(after several attempts)- an adult intact rat being used as
rodent carrier prior to mosquito passage, and a male C57 mouse
used as a recipient for the sporozoite infection which was
accomplished by the natural feeding method. The line was then
cloned in mice.
Growth tests in both rats and mice were carried out
periodically, the test animals receiving inocula of 10° para¬
sites via the intraperitoneal route. One test was carried out
in which the mean inoculum size was only one parasite per
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aliquot. After selection,responses to pyrimethamine and PABA
requirements were also estimated by the methods previously
described.
(10) Immunosuppression:
Immunosuppression was effected either by splenectomy
(Schnitzer et at, 1946) or following the administration of the
corticosteroid prednisone (Carrescia, 1961; Schmidt and
Squires, 1951).
Corticosteroid immunosuppression was used as an adjunct
to some selection experiments in which the importance of host
immunity acting against recrudescent lines was being investigated
with the hope of eventual whole or partial elimination. A few
mice were splenectomised for the sake of this cause also.
Rats were splenectomised during the development of the rat
adapted line of p.chabaudi and prior to use as rodent carriers
of the biparental blood infections.
a. Splenectomy
Before being operated on each animal was anaesthetised in
an ether jar and shaved on the left flank thus exposing the
concentration of splenic blood vessels underneath the skin.
Instruments were flamed beforehand but no other sterile pre¬
cautions were taken and in no case was septicaemia observed
afterwards. After incision the spleen was removed intact by
cutting the blood vessels without cauterisation. Bleeding was
hardly ever fatal and animals were normally active within 24
hours. The incisions were closed with metal suture clips.
b. C orticosieroid lamunosuppression
Prednisone (Sigma. Chemicals) was chosen for immuno-
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suppression for its cheapness and relative efficacy (Carrescia,
1961). 100 rag was dissolved in 50 ml warm ethanol which, was
then used to supplement 2.51 of drinking water with or without
PABA. Since a 20g mouse was observed to consume about 4- ml of
water per day - this corresponded to a daily dose of 8 nig.kg
which was probably in excess of the dose required.
(it was observed that non s.p.f. mice very often became
ill about 2 weeks after the commencement of immunosuppression
and this was reckoned to be due to the weakening of immune
controls on subpatent infections of unknown origin.)
(11) Estimating Acquisition Rates of Drug Eesistance
During single session drug selection experiments which are
commonly conducted over a few days, very high doses approaching
the maximum tolerated by the host species, are used to prevent
the recrudescence of those sensitive parasites which might
escape drug treatment. This type of survival can be viewed as an
inevitable consequence of biological variation and its extent is
a consequence of the numbers of parasites being treated. (See
Martin and Arnold, 1968 for a discussion of this point.)
Another undesirable implication of short-term, high-dose
drug therapy is that many resistant parasites will perish since
these doses commonly exceed their plasmodiostatic doses as well
as those of the sensitive parasites. Moreover, at the height of
such a selection pressure the number of resistant parasites will
be at its lowest so they will be hypersusceptible to the vagaries
of biological variability.
These twin dangers can be largely avoided by applying a
prolonged con stent dose between the plaoiaoidiostatic doses of
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sensitive and resistant parasites. While such methods are
common place in vitro they are well nigh impossible to achieve
in vivo. The nearest approach to this ideal in vivo in the
present study lias been the use of total withdrawal of PABA as
a selective agent against parasites with a growth requirement
for this substance such as some pyrimethamine resistant lines.
Thus the estimates of acquisition rates of sulphadiazine
resistance superimposed in this way are considered the most
reliable to date. Furthermore, for such a transformation the
scoring system of growth vs no growth on a PABA free diet is
simpler and easier to interpret than quantitive measurements of
drug resistance. This had made possible the scoring of larger
numbers of mutants than would have been possible otherwise. In
the case of estimates of the acquisition rate of pyrimethamine
resistance a constant drugging technique has been used. Doses
approximating the midpoint of the plasmoidiostatic doses of
sensitive and resistant parasites have been applied up until
the emergence of recrudescent parasites or until 20 days if these
fail to emerge. Since recrudescent parasites so treated tended
to emerge at or around the sixteenth day of treatment compared
with the twelvth day in the case of short-term, high-dose
taerapy, the parasite population sixes in either case cannot
have differed that much nor the consequent risk of scoring
multiple mutants. Furthermore the rather long biological half
life of pyrimethamine (Brooks et ah, 1968) would further tend to
minimise any such discrepancy.
(12) Genetic Techniques:
a. Standard crossing procedure
The general method for conducting crosses tietv/con lines oi
rodent/ malaria parasites has been describee elsewhere (iSa lliker
et al. , 1971, 1975). -This method has been summarised
diagrammatica 1 ly iu Fig. k,
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ytandard Crossing Procedure for ilodcnt
Plasmodia Using Mice as nodenl Carriers
of the Mixed Parental Blood Mixture
Routinely bloods f'rosi both the lines being crossed were
harvested from mice at the time of peak fertility which was taken
as being when exflagellating micro gametocytes were easily
detectable in a coverslip blood preparation examined under phase
contrast at 4-OGX magnification. Typically this occurred at or
around the tenth day after inoculation. The two bloods were then
mixed and adjusted so that the final mixture contained roughly
equal numbers of such exflage1lating micro gametocytes. About
0.5 to 1.0 ml of this blood mixture was then injected intra¬
venously into each carrier mouse which was then placed inside a
cage of starved mosquitoes.
Samples of these were then removed after 8 days and on
successive days and dissected.Oocyst counts were then performed
and given a sufficiency of mature oocysts sporozoites were
harvested at or around the fourteenth day after the blood meal.
b. Modii'ied Crossing Procedure using Splenectomised Rats as
Rodent Carriers of the Eiparental Blood Mixture
Since P.chabaudi was found to produce a greater number of
gametocytes in splenectomised rats than in mice (see pp<o5-fe8 and
MacLeod and Brown, 1976), this host was substituted for mice in
most of the later crosses reported in this study, (Some
difficulty had been experienced in crossing P.chabaudi by the
standard method and this had been attributed to its relatively
low fertility when compared with P.yoelii which had been rather
less troublesome in this respect.) The modification has been
summarised in Fig. 3.
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Following the use of the modified technique a large
increase in oocyst numbers was observed though accurate counts
were not performed, and the variation between individual
mosquitoes was large. It seemed reasonable therefore to attribute
the greater success rate in crosses and transmissions to the
enhancement of gametocytogensis in rats.
A
In the modified technique peak infected bloods were
harvested from mice infected by the two parental lines and the
pooled mixture adjusted to contain equal numbers of parasites
from each of the parents. However in some crosses between AS and
AJ lines, the mixture was adjusted to contain a slight preponder¬
ance of the latter since control studies suggested that AS
parasites outgrew AJ parasites in rats (see Table 15). Whenever
this was done it has been ;mentioned:' in the results section.
Fortunately if parasite matings occurred at random the effects of
unequal numbers of parents would have been minimised by the
buffering effect of the consequent binomial production of hybrid
zygotes. This effect has been illustrated graphically in Fig.4,
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into each splenectomised rat, by the intravenous or intra¬
peritoneal routes. If the blood had been packed by centri—
fugation and the supernatant discarded it was possible to inject
10
as many as 10 parasites in this way and typically instantaneous
rat parasitttemias of 2Q-30fl were produced. Since the
numbers of gametocytes produced was related to the size of the
infection (see Discussion) large rat parasitaemias were considered
conducive to success in crossing P.chabaudi lines using the
modified procedure.
Peak garnetocytogenesis in rats usually took place between
the third and sixth day after inoculation. Carrier rats were
then anaesthetised (Nembutal) and left in a cage of starved
mosquitoes. Subsequent procedures remained unaltered.
c. Crossing Procedure using the Membrane Feeding Apparatus
For some crosses neither rats nor mice were considered
suitable hosts for carrying parental blood mixtures prior to
mosquito passage. (it had been planned to use rat adaptation
as a marker in crosses with unadapted lines and the use of rats
might have conceivably had a selective effect on parasites of
the unadapted parent line.) Instead bloods containing peak
levels of gametocytes were harvested from each parent line, and
after mixing transferred to a water jacketed flask with an
inner diameter of about 3 cm. The temperature of the flask was
maintained at 35°C by a circulating water supply from a thermo¬
statically controlled water bath. Mosquitoes were allowed to
feed on these bloods through a thin parchment membrane. In
prolonged feeds the bloods were replaced every 20 minutes.
Subsequent procedures remained unaltered.
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d. Techniques used in anal/sing;- crosses
Blood parasites were harvested from mice inoculated with
cross product sporozoites and then either preserved in liquid
nitrogen or analysed immediately. Parasites from the original
biparental blood mixtures were used as controls for hybridisation.
Although the analysis of each cross differed in procedural
detail the common substantive features of cross analysis have
been summarised below and any departures from this convention
indicated in the relevant parts of the results section.
(i) Testing for hiparental transmission: In most crosses
the parents possessed distinguisable variants of the enzymes LDH
and 6PGD. The presence of both variant forms of either enzyme
among the products of the cross was taken as proof of biparental
transmission. However, electrophoresis was usually restricted
to LDH since variants of this enzyme were easier to detect on
starch gels by staining.
(ii) Testing for hybridisation; A variety of tests were
used. In crosses where these enzyme variants were segregating
and one of the other parental traits was amenable to selection
conditions restrictive to the other parent were enforced e.g.
by drug pressure or by PABA restriction. The presence then of
both forms of LDH or 6PGD was taken as proof of recombination
and therefore of hybridisation.
Some crosses were expected to generate a non-parental type
of recombinant whose phenotype permitted it to grow in
conditions restrictive to both parents. The presence of these
following the enforcement of such restrictive conditions among
the products of the cross but not among the biparental crontrol
mixture was taken as proof of genetic recombination and there—
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fore of hybridisation.
(iii) Clone ana1ysis; The basic method of analysing crosses
involved isolating lines derived from blood infections induced
from dilution clones. Each cloned line was then tested for a
number of characters such as drug response and isoenzyme type.
The majority of time spent in analysing crosses was occupied
doing this type of work.
(iv) Parent line controls; The stability of drug resistance
phenotypes among the parental lines used in the crosses was
tested routinely after mosquito passage. For logistic reasons
these control studies were not carried out at the same time as
the crosses themselves but rather when the opportunity arose.
In no case was resistance found to have significantly altered due
to mosquito transmission and consequently no data have been
presented.
e* Technique for harvesting single oocysts:
Oocysts were removed from guts by micro dissection on a
depression slide using tungsten needles sharpened in molten
potassium chloride. Guts were dissected from mosquitoes 12 to
13 days after a mixed blood meal i.e. before oocyst rupture was
widespread. Micro dissection and washing were carried out in
modified Kitamura's medium and VP 12 medium (Pudneyand Varma,
1971) by circulating ice-cold water. After washing each oocyst
was ruptured using a sharp tungsten needle and the sporozoite
suspension injected intravenously into a stock mouse. Control
mice received the wash only. Both the appearance of each oocyst
(mature or immature) and the ease with which the suspension were
injected were noted. A third group of mice received larger
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Selection for Drug lie sis taxice Mutants
In this section the details of the selection experiments
themselves have been preceded by base line drug response data
of the v/iId type lines which were the ultimate ancestors of all
the mutant lines, In classifying a line as resistant therefore,
it was required to exhibit a drug response significantly
different from that of the parent line undergoing selection.
The characteristics of these so called resistant lines have been
presented in the results section together with their frequency
among all types of recrudescent parasites and the experimental
details of the selection experiments themselves.
The rationale of classification has been explained in each
case in the discussion section.
In some cases lines which had been made resistant by one
treatment were subjected to a further bout of selection to create
doubly resistant mutants. In one case a putative triple mutant
was selected, but this was not tested genetically. To help in
following these rather confusing lines of ancestry a genealogy
of all these types of line together with the main examples of
each type has been presented in the appendix in Table 29.
a. "Wild Type Baseline Data
(All data refer to experiments performed using the standard
rat cake diet and PABA supplement of 0.5gl ) unless otherwise
stated.
(i) EABA supplement: Whereas the CR line of P.petteri
exhibited a shallow response curve to PABA restriction (E. Carter
unpublished results, confirmed by the present author) both the
AJ and AS lines of P.chabaudi exhibited a sharp decline in
growth at restrictive PABA levels. However before January
1975, both the wild lines of these parasites were able to grow
in the absence of any PABA supplement but after this date the
requirement for peak growth (symbolised by "+" in the text) had
increased to 0.025gl *. At zero PABA no growth (symbolised by
in the text) was possible. (For all lines used in this
study supplements stepped on the series zero, 0.025, 0.050gl \
enabled all or none growth whereas supplements between these
steps gave variable growth responses and data from these .have
therefore been omitted. Consistent growth responses at these
PABA steps were exhibited by all lines within the two time zone
before;, ox- after Jan. 1975). Baseline wild type PABA responses
for these two time gones have been summarised in Table 1, and a
summary of growth responses for all lines lias been presented in
Table 28 in the discussion,
TABLE 1 - on accompanying page
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table i
Wild, type lines: all or none growth responses (-1- or —) at
normal and diagnostic levels of PABA supplementation before
and after Jan. 1975,





Line (40mg.l )* 0 „ 5 0.05 0.025 Zero
AS Before Rat Cake Not Given 4" -I- + +
-AJ n 11 it II II + + + +
AS it n n Given + + +
AJ ft i! m I! + + + 4"
AS After » " Not Given + + -
AJ tf It IT if n + -i- + -
AS n Milk Diet tf ti + 4~ + -
AJ u it it n tf + 4- 4* -
administered for at least 7 days prior to inoculation.
Thus, while the minimum PABA growth supplement for wild type
lines irrespective of diet was Zero before Jan. 1975 it rose
to 0.025gl~' afterwards. The reason for this change has been
considered in the discussion.
The prednisone data have been included for convenience
of comparison and were obtained as formal control data for the
selection experiments conducted using this compound as an
immunosuppressive agent. There was no evidence that prednisone
affected PABA dependence.
(ii) V>ilei type responses to Sulphadiazine: estimates
+, 1 standard error range have been presented in Table 2. Where¬
as the estimates obtained before Jan. 1975 refer to responses
without a IJABA supplement those after that date were obtained
with the standard supplement as neither wild line was able to
grow in the absence of PARA.
TABLE 2
Wild type lines: responses to Sulphadiazine (EDgo)
Wild Before/After PABA Supplement Response to
, Sulphadiazine
Line Jan. 1975 (gl~ ) Li) (mg.kg-1 )
+ 1SE range
AJ Before Zero 0.054(0.049-0.059)
AS " " 0.061(0.047-0.074-)
AJ After 0.5 80.3 (51.3 - 126 )
AS " 0.5 61.0 (52.5 - 70.8)
(iii) Wild type responses to Pyrimethamine: EDgg estimates
+ ISE range have been presented in Table 3. All the estimates
were obtained with the standard rat cake diet whether before or
after Jan. 1975.
TABLE 3 - on accompanying page
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TABLE 3
Y/ild Before/After PABA Prednisone Response to Pyrimethamine
Line Jan. 1975 fU,' -» 40 mg.l EBnA(rng.kg~ ) + ISEg • i« yu
AJ Before Zero Not Given 0.116 (0.096 - 0.141)
AJ !l 0.05 1! f! 0.95 (0»48 — 1.89 )
AJ II 0.50 ft II 0.87 (0.53 - 1.41 }
AJ I! 1.00 II II 0.90 (0.59 - 1.47 )
AJ 1 1 0.50 Given 1.03 (0.81 - 1.50 )
AJ After 0.50 Not Given 0.98 (0.87 - 1.10 )
AS ii 0.50 II II 0.58 (0.38 — 0.89 )
The variations between these estimates except in the case of the
Zero PABA supplement were not significant arising from random
errors and measurernent errors.
The relationship between response of a wild type line to
Pyrimethamine and the level of :-'the PABA supplement has been
expressed graphically in Fig. 5.
FIG . 5
AJ wild type: Pyrimethamine sensitivity at 4 levels of PABA
supplementation (data obtained before Jan. 1975)
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B* viiicl Type Lines: Selection Experiments
(i) Pyrimethamine: Data concerning the frequency of
recrudescent infections after pyrimethamine selection at various
doses and dose rates and with or without PABA supplementation,
are presented in Table 4. Data on the effects of immuno¬
suppression by splenectomy or by administration of prednisone in
— 1
the drinking water (40 sag. 1 ) have also been included.
A summary of the characteristics of a selection of these
recrudescences — based on initial drug test and PABA test data
is presented in Table G along with comparable wild type and
resistant line data. (The resistant line was selected Dr. 3D.
WaHiker of this laboratory) by exposing a growing infection of
the AS wild type line of P.chabaudi to 4 consecutive daily
doses of pyrimethamine (50 tag.kg *) and called AS Hi DW.)
More comprehensive data (obtained after cloning) have been
presented for si selection of these lines in Table 6. These
included both some apparently "resistant" lines as well as those
lines which could not be classified with reasonable certainty
after the initial tests — i.e. so called anomalous lines. The
initial classification was based on the test data in Table 5
revised if necessary after more comprehensive tests (see Table 6).
In all but 2 dubious cases the comprehensive tests performed on a
sample of lines (n = 12) agreed with the initial classification.
TABLE 4 - on accompanying page
u. 401 402 403 404 405 406 407 408 409 410 411 412 413
TABLE4
Wildtypelines:pyr methamineselectio :Eff tsofvaryingd s . Doserat .PABAsupplementndimmunosuppr ssionthfreq cy andcharacteristicsofrec ud scentinfe tions.(Alld apreJ . 1975)
lineunder¬ going selection
Pyrimethamine dosetimes (mg.kg"")given
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Y/ilti type lines: pyrimethamine selection. Results of initial
tests performed, on lines derived from recrudescent infections.
(Comparable data on wild type and pyrimethamine resistant lines
included)
Ref. No. Selection Response to Growth Initial Eate
expt. »fl Pyrime¬ on 2 3 *
obtained thamine Zero class-
from ref. (fo control) PABA* ifica-
no. (see (% ti on
Table 4) control)
AJ wiId (<0.24(2.5) + 200
type - (<0.32( 5 )mg. kg
ASP1" (l)w) - (163 (2.5)
(180 ( 5 )
-<0.40 - —
4021 402 <0.3 + 104 w.type abandoned
4022 402 <0.5 - 38 1! II if
4023 402 25 -<0.4 resis. 11
4024 402 30 -<0.11 ii 11
4025 402 138 -<3.7 ii ii
4026 402 76 -<0.17 ii ii
4027 402 131 -<0.03 ii retested
4028 402 56 ~<u. 16 ii ii
4029 402 339 -<0.35 ii it
4041 404 < 0.24 + 22 w.type abandoned
4042 404 <0.13 + 76 ii ti
4043 404 <0.54 + 42 ii ii
4-044 404 < 0.80 +<0.30 anom. retested
(sensitive
4051 405 <0.30 + 218 w.type abandoned
4052 405 <0.31 + 17 it ii
4053 405 <0.75 + 49 1! ii
4054 405 no data + 98 If n
4055 405 132 + 85 axiom. •retested
{sensitive
4056 405 180 no data resis. ii
4061 406 15 -<0.13 ! 1 n
4081 408 <1.7 + 169 w.type abandoned
4082 408 <0.22 + 165 ii ii
40 83 408 <1.5 no data ! 1 ii
4084 408 <0.11 + 25 1! ii
4101 410 132 — <0.30 resis. it
4102 410 54 -<0.17 ii ii
4103 410 59 -<0.14 ii n
4104 410 92 — <0•14 if ii
4105 410 249 -<2.2 u ii
4106 410 22 -<0.32 ii it
4107 410 119 —<0.31 ii it




Kef. No. Selection Response to Growth Initial Eate
expt. 41 Pyrime¬ on 2 W 3 *
obtained thamine Zero class¬
from ref. {% control) PABA ifica¬
no. (see (7° tion
Table 4) control)
4109 410 100 -<0.34- resis. retested
4121 412 41 -C0.12 it abandoned
4122 4-12 133 -<0.32 n n
4123 412 71 -<0.33 ! I ii
4124 412 61 -<0.41 11 • ii
4125 4-12 108 -<0.17 ii retested
4126 412 158 + 106 anom. lost
4181 413 <0.13 + 41 w • type abandoned
4132 413 <0.48 i 129 ii ti
4133 413 < 1.37 + 169 ti n
4134 413 <1.00 + 48 ii ii
4135 413 <0.69 + 18 n n
4136 413 <0.23 + 135 ii ii
4137 4-13 <0.10 + 164 ii
4138 413 284 -<0.61 resis. retested




* 1 4021-4084 received 4 doses of 5 mg.kg .
■ 4101—4139 " 4 " of 2.5 mg.kg
*2 + = reached peak; - = failed to grow
*3 The resistant class includes ail those resembling
AS pit B v/





Wild type lines: pyrimethamine selection: Results of further
tests performed on selected lines obtained from recrudescent
infections. (Comparison data 011 a wild type line and 011 a
resistant line (ASpR DW) included).
„ Pyrimethamine jo Growth on Zero Classification
ED (range + PABA (range +_ w.r.t.
Number ISEjf ISE) (pre Jan. pyrimethamine
1975)
wiId type 0.87 (0.53/1.41) 51.4(19.4/136) sensitive IX )
ASP%)w 19.5 ^13.3/26.9 <0.26 resistant 22X )
AJ 4-027 18.2 (13.0/25.7) <0.21 resistant 2IX )
AJ 4028 7.8 ( 3.6/16.7) <0.32 if 9. OX)
AJ 4029 21.8 (13.3/35.6) <0.22 11 25X )
AJ 4044 1.10 (0.64/1.89 57.5(28.2/117) sensitive 1.3X)
AJ 4055 A o 0\) • oci (0.14/0.74) 128 (38.6/429) 11 0.37X)
AJ 4056 24.5 (15.0/41.8) <0.95 resistant 28X )
AJ 4061 22.5 (13.2/33.4) < 0.40 n 261 )
AJ 4108 12.2 (8.60/17.4, <0.25 11 14X )
AJ 4109 17.3 (13.0/23,1 <0.31 11 201 )
AJ 4125 18.5 (12.9/26.9 <0.24 11 2IX )
AJ 4133 10.9 ( 6.4/19.1 ^ 0.14 it 13X )
AJ 4139# 2.14 (1.56/2.95 122(48/310) anom. 2.5X)
or sensitive
fk for data concerning the response of this line to
sulphadiazine — see Table 8.
It was concluded that the lines classed as resistant resembled
ASf^DW both in the level of pyrimethamine resistance acquired
and in the concomitant PABA dependence. The basis for the
classification lias been considered in more detail in the
discussion along with estimates of the acquistion rates. The
anomalous line AJ 4139 was later classified as resembling
sulphadiazine resistant lines obtained by direct exposure to
the drug or following PABA restriction and has been discussed
along with these.
A
(ii) tvild Type Lines: Selection with sulphadiazine (pre
Jan. 1975) and by restriction of dietary PABA (post Jan. 1975).
The direct drug pressure selection experiments were
completed prior to the PABA shift in Jan, 1975 but drug testing
of the recrudescent lines was not completed until after that
date. Consequently all lines still available were retested
under the new PABA regime and only these data are presented.
Both the PABA restriction experiment and the testing of the re¬
crudescent lines obtained after selection in this way'were
carried out under the new PABA regime after Jan. 1975. All
experiments were performed using the AJ wild type parasite line
Data concerning the frequency and characteristics of
recrudescent lines obtained after direct drug pressure or after
indirect selection by PABA restriction are presented in Table 7
.Sulphadiazine and Pyrimethamine response data for some of these
lines are presented in Table 8 together with data on one of the
anomalous lines obtained after pyrimethamine selection by
-1
exposure to a constant dose of 2.5 mg.kg pyrimethamine.
Comparison data on a wild type line and on a member of the
predominant class of pyrimethamine resistant lines (AS s^" Dh)
have been included.
All the direct drug selection experiments were performed
with no PABA supplement being given.
TABLE 7 - on accompanying page
TABLE7









































































*1immunosuppressionbyadministrationfprednisoneidrinki gwa er(40g.l_i) *2ofthe26lin sclassedsulphadiazinere i ta tonly8weredir c ltest . Theresistanceoft oth rshasbinferredf omt irPABA.d pendence PABAindependence(aft rJan.1975)wasalwaysfou dtbassociatedith sulphadiazineresistanc .
TABLE8
Wildtypelines:se ectionwi hsulphad azineandbyPABAre triction:r sponses tosulphadiazineandyrimethaminendgrowthoPABAfrd et(aft rJ . 1975)togetherwithr levantcomp risonda . BDgo(±ISErange)mg.k "1)Anornone
Linehow—*1growonClassification obtainedc..,_..z roPABASulphadiazmePyrimetha ine(aftel.Jan..75)
AJwildtype- ASP11DW)exposureto AJ4139)pyrimethamine AJ7031 AJ7032 AJ7041 AJ7042 AJ7054 AJ7056 AJ8015 AJ8016 AJ8017exposuret sulphadia¬ zine (expts.703 -705) PABAre¬ striction (expt.801)
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pyrimethamineresist.*3 anomal.sulph d.resist sulphadiazineres st. ft II sens.recrudescence sulphadiazineres st« ti t
*1+=reachedpeak:-failetogrow. *2EDg0sulphadiazine(preJan.1975)=.30m kg(0 64-2. 2) *3SeeTable6
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Characteristically the lines classed as sulphadiazine resistant
were all PABA independent after Jan. 1975 and showed a
continuously variable cross-resistance to pyrimethamine also,
thus resembling the anomalous line AJ 4139 obtained after
exposure to pyrimethamine. There seemed to foe no correlation
between the mode of selection (direct or indirect) and the
phenotypes produced. Although sensitive recrudescences were
detected (following direct exposure to drug pressure only) no
intermediate types were identified. These are further explained
in the text.
c. Mutant Lines - Selection Experiments
The main aim of the selections performed on the wild lines
was to obtain an estimate of the range of basic genetic
variation available by inference from the range and frequency
of the different resistance phenotypes produced. Having obtained
these it was planned to demonstrate their combination by genetic
means-as shown in Cross 5.
On the other hand selections were performed on mutant lines
with a view to investigating the ease with which single gene
mutants could foe combined by selection and later dissected by
genetic means-as shown in .Cross 4.
It was hoped that the combination of these two approaches
could be used to investigate to what extent simple aendelian
genes could be invoked to explain the inheritance of multiple
drug resistance.
Sections (i) and (ii) deal with the case where single gene
mutants which had been made resistant either to pyrimethamine or
to sulphadiazine by direct drug exposure were subjected to
secondary bouts of selection designed to induce resistance to
56
the alternative drug also: thus both may be considered as
alternative routes to the same genetic eadpoint.
In section (iii) this double mutant was exposed to a third
bout of selection (by PABA restriction) to create a presumed
triple mutant — though this line was not tested genetically.
In addition the selection experiments involving PABA
restriction of lines in which this substance was required as a
growth supplement following the acquisition of pyrimethamine
resistance were used to detect any back mutations to pyrime¬
thamine sensitivity. (PABA independence due to the acquisition
of sulphadiazine resistance would be distinguishable from that
due to back mutation as in the former case no loss of pyrime¬
thamine resistance would be expected.)
(i) Pyrimethamine resistant PABA do pent.:out lines -
secondary selection by PABA restriction: The minimum level of
PABA supplement required for normal growth by these lines rose
from 0.025 gl~* to 0.050 gl~* after Jan. 1975. However despite
this increase all the PABA restriction experiments involved the
total withdrawal of the PABA supplement. Since the suppressive
effect of this restriction was not immediately apparent the PABA
was removed at modal parasitaemias between 0.1 and 1.0/b,
Typically this meant that the mean maximum parasitaemias of lines
undergoing selection were between 5 and 15fc. These maxima were
used in calculating the number of parasites which had undergone
selection.
Data on the frequency and characteristics of recrudescent
lines following selection have been presented in Table 9 along
with data on the effects of the administration of prednisone as
an immunosuppressive (40 log. I in the drinking water.) The
TABLE9
Pyrimethaminer sistantPABAdependentlines:eco darys lec ionbyPABArestrictionandtheeff ctsofimmunosuppre sion(bypred isone) onthefrequencya dcharacteristicsofr cru es entlin .
Ref. No.
line under¬ going selection(gl~')MinimumPABAExperiment„.No.treated GrowthBefore/mPeCiparasites RequirementAfterr ^~ (x10^®)Jan.1975men
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Pyrimethamine resistant PABA dependent lines PABA restriction
selection experiments. Growth of recrudescent lines in the
absence of PABA and after pyrimethamine therapy (4 x 20 mg.kg )
- both expressed as a percentage of the untreated control.











(4 x 20mg.kg )















• 5mg»kg:.±- 4) ■
AS 90101 * ' PABA
T «*•
restriction + 45 49
AS 90102 *-1 it + 7.5 78
AS 90103 * ' ii ii + 250 OOAcioU
AS 90104 ii ii + 24 143
AS 90105 ii ii + 5.4 27
AS 90106 ii ii + 22 76
AS 90107 ii + 3.6 183
AS SO 100 ii n + 450 173
AS 90109 it n + 613 20
AS 90110 ii it + 100 36
AS 90111 ii n + 96 28
AS 90112 ii ii + 45 Not tested
A3 90113 ii ii + 121 it it
AS 90114 ii 1! + 82 ii ii
















AS 90113 ii II + 1201
ii II
AS 90119 ii II + 67
ii ti
AS 90120 ii II -r 113
u ii
AS 90121 ii 11 + 340
ii ii
AS 90122 it II + 17
n ii
AS 90123 ii IF + 45
n ii
AS 90124 ii II + 44 ii ii
AS 90125 ii Tl + 116
II IT
AS 90126 *» ii II + 131 2.6
AS 90301-3(41 PaBa rest. & immun. + 31 73
AS 90302 ti TT n ii + 103 17
AS 90303 it II II it + 17 39
AS 90OU4 ii II ii ii + 115 ^9
AS 9U3U5 it " II it + 35 Not tested
>(firetest data presented in Table 11 3* 2 of AS P I)W
iiiiiiiun. = immunosuppression
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brief classification of these recrudescence included in fable
9 .have been obtained from results of the preliminary tests
summarised in Table 10 and from the more detailed tests, the
results of which have been summarised in Table 11.
TABLE 11
Pyrimethamine resistant PABA dependent lines: secondary selection
by PABA restriction. Response to pyrimethamine (El)go (iaS"Rg_,+.
IEE range) and growth in the absence of PABA (results of repeated
tests) of a selection of recrudescent infections. Comparison
data on the ancestral line included. (All data obtained before
Jan. 1975.y
Ref, No,
All or None and














































¥ 1 + = reached peak - = failed to grow
* 2 both these lines were selected by PABA restriction
also, but details have not been included in the
text.
f! 3 the mean value for increase of resistance = 1.7 X
While PABA restriction had restored the PABA independence of all
these recrudescent lines in no case was the resistance to
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pyrimethamine abolished either following the preliminary or
the quantitative drug tests where these were performed. On
the contrary, there was a mean increase of pyrimethamine
resistance of 1.7 X.
(ii) Sulphadiazine resistant lines: continued selection
with pyrimethamine: (see previous section) AJ 7032 which had
been made resistant to Sulphadiazine by direct exposure to the
drug (4 x 5 mg.kg) was also cross resistant to Pyrimethamine
(ISDqq = 2.19 mg.kg ) i.e. about two fold compared with wild
type lines. A second bout of selection was imposed by direct
exposure to pyrimethamine administered continuously until
recrudescences appeared for up to 20 days following commencement
of drug treatment. Mice received the normal PABA supplement of
0.5gl Details of the frequency and characteristics of
recrudescences have been summarised in Table 12 and their
responses to pyrimethamine and PABA have been summarised in
Table 13. (All experiments and tests were performed after Jan.
1975.)
See the text for a further discussion together with
acquisition frequency estimates and an interpretation of the
results. Line AS 90301 was later used in a cross with a wild
type line (Cross 4) and in another selection experiment. (See
results, Section 1c (iii) ) .
TABLE 12 - on accompanying page
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TABLE 12
Sulpliailiaziiie resistant lines: secondary selection with
Pyrimethamine. Effects of varying dose on the frequency
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AJ7032 1201 40















Sulpiiaaxazxne resistant lines: secondary selection with
Pyrimethamine. Growth ijo control) after pyrimethamine treatment
(zi- x 20 mg.kg" ) and in the absence oi" a PAliii supplement. (Data
after Jan. 1975). Comparison data on AJ 7082 included.
fo Growth after % Growth without
line ref. seln. expt. pyrimethamine a PABA
no. ref. no. treatment supplement * 1
AJ 7032 703 <0.23 + ( 87 )
AJ 12021 ¥ 2 1202 111 - ( < 0.37)
0.19)AJ 12022 1202 17.8 - ( <
AJ 12023 1202 30 - ( < 0.75)
AJ 12024 1202 61 _ /V < 0.40)
AJ 12025 1202 236 - ( < 0.28)
AJ 12026 1202 100 - (\ < 2.5 )
AJ 12027 1202 56 - ( < 0,95)
AJ 12028 1202 59 - ( < 0.80)
AJ 12031 1203 4 - ( < 0.13)
AJ 12032 1203 687 - ( < 1.0 )
AJ 12033 1203 267 - ( < 1.2 )
* + = reached peak * (ED90) pyrimethamine was later
12= failed to grow ^ found to be 31.32 rag.kg" -
IEE range 23.44- — 42.66 rag .kg ' )
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It was concluded that the secondary selection by exposure
to pyrimethamine had significantly increased the resistance to
this drug in all the recrudescences tested. Although only one
quantitative measurement of this increase was obtained, there
was no reason to suppose this to be atypical. This line AJ
12021 resembled closely the double mutant lines obtained by
PABA restriction of pyrimethamine resistant lines which required
this growth supplement. In effect both were thought to
constitute alternative routes to the same end. (This has been
further discussed in the text together with estimates of the
acquisiiion rates.)
(iii) AS 9Q3Q1 double mutants; tertiary selection by
PABA restr.iction: AS 90301 which had been isolated after two
selection steps: firstly by direct exposure to pyrimethamine
— 1
(4 x 50 nig.kg ) followed by PABA withdrawal was able to grow
in the absence of PABA before Jan. 1975 but required a supplement
of 0.025 gl * after that date. Consequently the line was
allowed to undergo a second round of PABA restriction after
that date. Mice with growing infections of AS 90301 parasites
had their PABA supplement removed entirely and the maximum
number of parasites was estimated to have reached 2.2 x 10lw.
Subsequently 4 recrudescent lines were detected and preliminary
tests indicated that all of these had become PABA independent.
After cloning measurements were made of their responses to
pyrimethamine and PABA growth requirements. These data have
been summarised in Table 14.
TABLE 14 - on accompanying page
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TABLE 14
AS 90301: characterisation of 4 recrudesceut lines isolated
after a second step of PABA restriction along with
characteristics of the original line that underwent selection.
(All data obtained after Jan. 1975.)
Pyrimethamine PABA
EDQ^(mg.kg)+ ISE win. Growth suppl.
range to reach peak(gl~' )
AS 9030l(original line) 34.5 (25.7—46»3 j 0.025
i'i.O 90301141 ) 42.4 (32.4—55.6) Zero
AS 90301142 ) rccrue- 3u•3 (24.0—43.5j Zero
AS 90301143 ) escon t no data Zero
AS 9030114-4 ) lines 28.3 (25.1-32.0) Zero
This second round of PABA restriction had resulted in a
return to PABA independence in all the recrudescences tested.
There was no evidence of any significant change in pyrimethamine
resistance though it was inferred that sulpliadiazine resistance
had been increased. The significance of these data have been
discussed in the text.
(iv) Conclusions: Data from the PABA restriction
experiments in (i) and (iii) showed no loss of pyrimethamine
resistance following selection and therefore no evidence of back
mutati on.
The mutant plieno types described in sections (i) and (ii)
appeared indistinguishable on phenotypic grounds and were
presumed to have resulted from the combination of two single gene
mutants conferring resistance to pyrimethamine and sulphadiazine
respectively.
The mutant described in section (iii) was presumed to
be a triple consisting of one pyrimethamine mutant and two
sulphadiazine resistance mutants. Its existence demonstrated
that more than one type of mutant conferring sulphadiazine
resistance was available — a finding possibly relevant to the
rather wide range of pyrimethamine cross resistances observed
following selection for sulphadiazine resistance e.g. in




Selection for hat Adaptation^ in p.chabaudi
In order to obtain a selective marker unconnected with drug
resistance intended for use'in more detailed analyses of the
genetics of drug resistance, a rat adapted line was obtained by
selection.
Data on the mean peak percentage parasitaemias in male C57
mice and in newly weaned and 8 week old norway wistar male rats
reached by the wild type AJ line before and after selection and
after 4 mouse and 1 mosquito passage after selection are presented
in Table 15. Data on the responses to pyrimethamine and MBA
dependence before selection and after selection and mouse/
mosquito passage have been included (post Jan. 1975). All
inoculum sizes = 10^.
TABLE 15 - on accompanying page
During the initial development of the rat adapted line, large
numbers of male and female gametocytes were observed following
0
inoculation with more than 10 ' parasites or so. With these
large inocula nan adapted parasite infections peaked at between
4 and 6 days in splenectomised rats and gametocytes could be
observed from initial appearance at about 2 days through a peak
at between 4 and 7 days and remained visible for up to between
14 and 28 days after inoculation.
Data on peak levels of infection and game oocyte production
for three lines in the different hosts used in this study are










35.8(40. )23 126 36.67(7. 0) (31.4)20 3(5.85)





effectsofraad ptation ResponsetPyrime¬ thaminemg.kg"' (ED^0+ISErange)*1
minimumPABA supplementfor growthtpeak*1
0.98(1.10).025$ (0.87) nottestednottested 0.96(1.12).025$ (0.83)
TABLE16
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0.24(0.41)23.26 3686 7(7 056 (0.14)20.3515 8546
*toofewanimalsrstand rderrorbedet rmine
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The data in Table 15 show that not only had. selection
rendered the surviving parasites capable of growing to a higher
parasitaemia in splenectomised rats than wild types, but also
had given them the novel ability to grow in intact rats; and
although data have not been presented, this extended to
infections initiated with clonal inocula. Growth in mice seemed
unaffected by rat adaption as were PABA dependence and pyrime¬
thamine resistance. Eat adaptation appeared to foe stable also.
On the other hand the data in Table 16 show that rat
adaptation seemed to have significantly reduced the phenomenon
of abundant gametocytogenesis observed in wild type infection of
rats — suggesting that this phenomenon was symptomatic of growth
in hostile or abnormal conditions.
All these phenomena have been discussed in the text. How¬
ever, the technique of selection by repeated passage prohibited
the calculation of the rate of acquisition of rat adaptation.
The rat adapted line was later crossed with a sulphadiazine
resistant line with a view to elucidating the mode of




Apart from the presumptive triple mutant type all the
main types of mutant ana mutant combination described in the
present work v/ere used in Crosses.
Crosses 1 and 2 concern the inheritance of pyrimethamine
resistance and Cross 3 deals with sulphadiazine resistance.
The main type of question posed in these crossing experiments
is to what extent the inheritance of these characters and their
correlated effects can be attributed to mendelian single gene
mutations - the simplest possible model.
Crosses 4 and 5 deal with the combined inheritance of
resistance to these two drugs with special emphasis on the
occurrence of recombination between them. Included also in
Cross 4 is a brief description of an unsuccessful attempt to
analyse this cross by the analysis of clones obtained from
single oocyst infections.
Cross 6 was intended as a necessary preliminary investigation
into the nature of rat adaptation prior to the use of this
marker as a selective tool in the screening of crosses with
drug resistance markers, and although this marker was shown to
be unsuitable the data have been included and discussed and
illustrate some of the problems attendant upon a genetic analysis
of mutants with complex modes of inheritance.
In each cross, the results have included a brief rationale
followed by a description of the parents and the cross products
and end with a short conclusion. Each cross has been discussed
in detail in the text. The discussion ends with general
conclusions regarding the nature of the inheritance of drug
resistance drawn both irom the selection experiments and from
the crosses themselves.
11
Cross 1 - AS P* (DW) (pyrimethamine resistance, PABA dependent
obtained by direct exposure to the drug in a single step) x AJ
wild type: further analysis to detect recombination between
primary resistance to pyrimethamine and the concomitantly
developed increased dependence on PABA and thereby test for
pleiotropy.
The analysis of this cross by clone analysis has been
reported elsewhere (V/alliker et ah, 1975). He kindly allowed
me to perform the further analysis using blood samples
preserved from the original cross.
(i) Description of parental phenotypes: The responses to
pyrimethamine and minimum PABA requirements (pre Jan. 1975) are
presented in Table 17,
TABLE 17
Cross 1: AS r JUS x AJ wild type, llesponses to pyrimethamine.
minimum PABA supplements required for growth (Data pre Jan.
1975) and enzyme markers.
iiesoonse to Pyrime— kin. PABA.sumo1.
Parent ,, . TWn x. " enzyme
,. thainme (ADon + ISA. lor growth oo . ,lines \ , . — , / ,-h variantrange) nig.kg-' peak \gl }
Lijjll U xLFI)
AJ wild type 0.-37 (0.53-1.41) Zero ~ 2
AS Bf 19.5 (13.3-26.9) 0.025
(ii) Experimental details: V/alliker et al. (1975) showed
free recombination between variants of the two enzyme markers LDH
and bPSl) and the qualitative character pair pyrimethamine
resistance/sensitivity. It remained uncertain however whether or
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not pyrimethamine resistance and PABA dependence segregated
together. To choose between these alternatives a test system
was set up to find any parasites in which pyrimethamine
resistance had lost its accompanying high PABA dependence.
The procedure was analogous to a 4 day drug test. Two
groups of mice were inoculated with 10° aliquots derived from a
cross product parasite stabilate preserver in hue laboratory.
^ . -1
One group receiver. 5 rag.kg pyrimethamine intraperitoneally
o hours later and on the o days following. The other group was
treated as a control and received carfooxymethy1 cellulose only.
On the fourth day after inoculation parasite counts were performed
on both groups of mice and these agreed closely, doubtless due to
the presence of resistant parasites in the drugged group.
5
Aliquots of 10 parasites were then obtained from both groups of
mice and each set used to inoculate a group of mice which had been
maintained without a PABA supplement and a group of control mice
— 1
receiving the standard supplement of 0.5 gl ' making 4 groups in
5
all, (The choice of 10 parasites was made as a compromise between
running the risk of selecting a mutant or a parental survivor by
weight of numbers and risking the exclusion of rare recombinant
types.) Animals in all groups except those which had received both
drug and PABA restriction became patent. These animals were still
cxear ax ter aO days. ^ had. parasxoes been observe^, as well as
being drug and PABA tested, the experiment would have been repeated
6 5 \
using smaller aliquots than 10 and 10 .J
This negative result was taken to demonstrate the absence of
pyr ime tannine resistant PAlAi independent paras i les among* tne
products of the cross, supporting the conclusion that the
increased level of PABA dependence found in pyrimethamine
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resistant lines resulted from a pleiotropic effect induced by
the primary genetic change.
Crosses 2a; 2b: 2c - AS F* |}f x AJ 4027; AS F Ml x AJ 4028;
AJ 4027 x AJ 4028, AH these were of the type: pyrimethamine
resistant, EABA dependent. While both parents in each of these
three crosses uad more or less indistinguishable phenotypes,
they had been obtained innependently and had possibly arisen due
to mutations at different loci. It was the purpose of these
crosses;detect any recombination between these possible loci,
by the use of a screening technique.
(i) Origin of parents: All three lines used in these crosses
were made resistant to pyrimethamine by single step selection and
had become concomitantly dependent on PABA. AS J*~ lit? as
mentioned previously, had been selected by Br. I). V/a lliker of
this department using 4 doses of pyrimethamine (50 nig.kg )', AJ
4027 and AJ 4028 had been selected using 4 doses of pyrimethamine
-1
(50 nig.kg ) . A summary of the parental phenotypes has been
presented in Table 18.
TABLE 18
Crosses 2a: 2b: 2c: parental phenotypes. Responses to
pyrimethamine, dependence on PABA (pre Jan. 1975) and enzyme
markers.
.Response to pyrime— Min. PABA suppl.
Line thamine (EBgg ± ISB for growth
range) fig.kg-' (gl_l)
Aib # BW 19,5 (13.3-26.9) 0.025 3 2
AJ 4027 18 o 2 (13,0-25,7) 0.025 2 3







(ii) Experimental details; 3 pair wise crosses were
performed, the first of these (AS P*" BV; x AJ 4027) was performed
twice using both the standard crossing procedure and the
modified procedure using splenectoaised rats as a rodent
carrier. The other two crosses were performed using the ..modified
procedure only. Sporozoites were harvested as previously
described.
Cross product bloods were examined electrophoretically in
crosses 2a and 2b and parental co-transmission confirmed in both
cases following the modified crossing procedure, but not in
cross 2a following the standard procedure and this blood was
discarded. Parental electrophoretic identity in the case of
cross 2c prevented this check being made.
u 4 2
Serial dilutions of 10 , 10' and 10 parasites per 0.1 ml
were prepared from each of the. remaining bloods and aliquots
used to inoculate groups of 2 or 4 mice (<? o C57) which had
received no PABA supplement for at least 7 days. Mice receiving
the full PABA supplement of 0.5 gl 1 were inoculated with 10^
parasite aliquots as viability controls. A further group of 2
p
zero PABA mice were inoculated with 10 parasite inocula
obtained from the AJ wild type line as a check on PABA dependence.
Mice were checked for patent infections after 5 days and
subsequently;the results of these tests are presented in Table
19,
TABLE 19 - on accompanying page
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TABLE 19
Crosses 2a: 2b: 2c: growth of cross product parasites in
mice receiving no PABA supplement, (pre Jan, 1375)
Composition of Size of mice inoculated No. mice with
inoculum inoculum m"o Wra patent*
supplement infections
2 _1
2a cross-prods 10 2 0,5 gl 2
2b cross—prods " a
2c cross-prods " 2 " 2
2a cross—prods " 2 zero 0
2b cross—prods " 2 " 0
2c cross-prods " 2 " 0
4
2a cross—prods 10 2 " 0
2b cross-prods " 2 " 0
2c cross—prods " 2 " 0
2a cross—prods 10 4 " 0
2b cross—prods " 4 " 0
42c cross-prods " 4 " 0
AJ wild type 10fc 2 » 0
The failure of cross product parasites to induce patent
infections in mice receiving no PABA supplement was taken to
indicate the absence of PABA independent parasites amongst them.
Thus there was no evidence of recombination between these 3
independently selected mutants suggesting that these loci
resided in the same or adjacent genes. This was taken as evidence
in support of the view that the phenotypic .homogeneity of this
class of mutant resided in their genetic homogeneity.
Cross 3: AS wild type x AJ 7031 (Sulphadiazine resistant). The
main purpose of this cross was to verify that.' the sulphadiazine
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resistance marker segregated in a mendelian fashion as a single
genetic factor.
(i) Origin and characteristics of parent: The AS v/ilcl
type line closely resembled its AJ counterpart in its response
to pyrimethamine (see Table 3), in its PABA dependence (see
Table l) and in its response to sulphadiazine (see Table 2) J
but differed from the AJ line in its electrophoretic variants
of 6PGi) and Lull. The AJ line used in this cross, 7031, had been
made resistant to sulphadiazine after receiving 4- doses of the
drug (5 rag.kg ). It had acquired a two fold cross resistance
to pyrimethamine also and grew to peak without PABA
supplementation unlike its wild type mate in the cross. (All
data post Jan, 1875). The phenotypes of the parents have been
summarised in Table 20,
TABLE 20 - on accompanying page
(ii) Experimental details: The cross was performed using
the modified crossing procedure with newly weaned
splenectomised rats as rodent carriers. Each rat was inoculated
intravenously with about 0,5 ml of peak infected blood composed
of 2 parts AJ 7031 parasites to 1 part AS parasites. This
ratio being chosen to partially compensate for the apparently
greater fertility of AS parasites in this host (see Table 16).
After 5 days exflagellation was observed and starved mosquitoes
allowed to feed on the rats.
Sporozoites were harvested 14- days later as previously
described and used to inoculate 3 C57 mice intravenously. All
TABLE20
Cross3:ASwildtypexJ7031(Sulphadiazineres stant)Pa ntal phenotypes:responsestopyrim thamineandsul hadiazineanPABA dependence(postJa .1975)
Line
ResponsetoPyrimethamineResponsetSulphadiazine (ED.q+ISErange)mg.kg"')(EDgo+ISErange)mg.kg 0.5gl"1PABApostJan '75)











of these mice became patently infected within 5 days indicating
the original syorosoite infection to have been, a heavy one.
Parental co-transmission was confirmed, electrophoretically
and parasites from 2 of the three mice cloned by dilution (0,83
parasites per inoculum). Of 108 mice so inoculated 14 became
patently infected and 12 of these clones were tested for their
responses to pyrimethamine and sulphauiazine and. for their
afcility to grow in the absence of any PABA supplement along with
samples from the parents making 14 in all. Control animals from
each test were later sacrificed and the bloods harvested for
electrophoresis, 11 C57 male mice were used in each test there
— 1
being: 3 controls; 3 dosed with sulphadiasine (160 mg.kg x 4)
-1 \
and 3 cosed with pyrimethamine (1.25 rag.kg x 4). All of these
received the normal PABA supplement of 0.5 gl . m addition
there were two animals which had received no PABA supplement for
at least 7 days beforehand. Otherwise this 4 day test was
conducted as previously described. Growth expressed as a
percentage of the controls was calculated for both drug closes
and. PABA restriction. The results have been presented in Table
21.
Two clones (CX 804 and CX 509) whose responses to
sulphadiazine rendered them difficult to classify were retested
using the same dose (160 rag.kg ^ x 4) of this drug. This time 4
mice were used in each treatment group.
After retesting the growth after drug treatment (expressed
as a percentage of the control) was 7.02 (4.03 — 12.21) i or
clone CX 804 and 94.5 (59.4 — 150) for CX 509.
Using these retest data the mean percent growth after drug
treatment with sulphadiasine (4 x 160 rag.kg ) was 124p for
TABLE21













































0.40-1.62) 47.9-6 0.43-2.77) 1.41-10.93) 0.23-1.51) 4.02-19.7))* 4.03-12.21)) 0.22-2.14) 0.60-2.35) 2.75-6.86)
nodata 8.09-52.6))# 59.4-150)) 29.9-78) 71.7-262) 71.0-579)
1.23(0.58-2.62) 40.1(10.7-15 0.25(0.13-50) 14.95(4.31-51.87) 0.72(0.28-1 86) 0.53(0.20-1 4 ) 2.38(0.70-8 0 0.68(0.16-2 95 1 .08(0.6-.95) 44.9 107 145
P̂ABAnosupplementEnzymeVariant
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those clones which grew in the absence of PABA and 1.80$. for
the non-growers. The figures for pyrimethamine (4 x 1.25 nig.
kg) were 50.0$ for growers and 1.22$ for non growers.
Tais enabled the 12 clones to be dichotomised: clones
CX 301 to 808 all exhibited wild type responses to sulphadiazine
ana to pyrimethamine and in respect of their PABA growth
requirements; on the other hand, clones CX 309 to 312 resembled
the resistant parent both in respect of their responses to
sulphadiazine and in their PABA growth requirements. While on
average the latter clones appeared more resistant to pyrime¬
thamine there was some overlap in respect of the measurements of
this character and this has been considered in the discussion.
Both sulphadiazine resistance and PABA independence
appeared to segregate together. Although this was probably true
of cross resistance to pyrimethamine also the evidence was less
clear cut. This suggested a pleiotropic origin for the
correlated characters.
There appeared to be free recombination with both the
enzyme markers 6PGB and LI3I1.
Cross 4; AJ wild type x AS 90301 (pyrimethamine resistant, PABA
dependence wild type): detection of non parental phenotypes
among cross products as evidence for recombination between
markers conferring resistance to pyrimethamine and to
sulphadiazine.
(i) Origin and characteristics of parents: Line AJ wild
type has been described previously (see Tables 1-3). Line AS
90301 was obtained by selection in two steps: AS wild type was
made 20 times resistant to pyrimethamine by direct exposure to
80
— 1
the drug (4 x 50 mg.kg ) in a single step (WaHiker et al.,
1975)5 ana this line which was EABA dependent was selected by
PABA restriction (Tables 9-11) — this constituting the second
step of selection. After the second step of selection which had
increased the level of PABA resistance to between 35 and 61
(range of estimates, mean = 46) times that of the viId type AJ
line used in the cross, the line was no longer PABA dependent
before Jan. 1975 but required 0.025 gl"1 for normal growth after
that date. Thus its PABA dependence (and sulphadiazine
sensitivity) was indistinguisable from that of the wild type
line in the cross. These phenotypes have been summarised in
Table 22.
TABLE 22
Cross 4: AJ wild type x AS 90301: Parental phenotypes:
responses to pyrimethamine and to sulphadiazine and PABA
growth requirements before and. after Jan. 1975.
Response to: (3Don + ISE) mg.kg * ,.4T,,
Parent 1 ~ x-aha
Line Before/ Pyrirae- Sulphadi&zine J> '.
After thiamine requi
Jan.'75 (0S$V) PABA .(oSgC') PABA Zero PABA ')
( before ^0.87(1.41) no data 0.054(.059) Zero
( (0.53) (.049)
AJ v.i Id (
"type ( | o
( after 0.90(1.10) 80.3(12.6) no data 0.025
( (..87) (51.3)




( after 284.5(46.8) 67.2(87.1) no data 0.025
( (25.7) (51.9)
1, not sig. diff.
3, " " "
not sig. diff.
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(ii) Experimental detaiIs; The cross and preliminary
analysis were carried out before Jan. 1975. However the detailed
characterisation of clones was performed after that date and this
has been indicated elsewhere as appropriate.
The cross was performed using the modified crossing-
procedure with newly weaned splenectomised rats as rodent carriers
of the biparental blood mixture which was adjusted to contain
equal numbers of parasites from each parent line.
The mixed parental blood meal was permitted to take place on
the fifth day after these rat inoculations and sporozoite
infections were induced by natural transmission. Cross product
bloods were split into samples for cry©preservation and immediate
analysis. The original biparental blood mixture was also
preserved and. used as a hybridisation control.
Enzyme electrophoresis confirmed parental co—transmission.
Dilutions containing 10 parasites per ml were prepared from
both cross product and control samples. Aliquots (0.1 sal) from
each sample were then used to inoculate two groups of mice
(C57 male) receiving no PABA supplement: the first group received
— 1
1.25 nig.kg sulpixadiazine and on the following 8 days; and the
other group was inoculated with Na CMC only as a growth control.
Undrugged control mice inoculated with both blood samples
became patent after 3 days. Drugged mice inoculated with cross
product blood parasites became patent between 2 and 3 days later
whereas those which had' been inoculated with the control mixture
remained clear of infection even after 16 days, suggesting that
all the parasites had been eliminated. These data revealed the
presence of a noil parental class of parasites amongst the
products of the cross: inferentially these were probably
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TABLE 28
Cross 4; AJ rile;, type x AS 90801. Characteristics of 30 cross
product clones and preliminary classification. (Data pftiSt Jan.
1975)
Enzyme Response to (^>UNT. f> Growth
Variant control) Zero PA Initial
LE'H 6PGD
<b Pyrimetli. ©> Sulphad.






401 3 2 72.8 - <0.20 + 46.4 )
402 oO 2 06. o — <0.30 + 74.4 )oul-pkaaiazine
403 3 C".cE 74.6 -<0.18 + 101 )sens. PABA
404 O 2 41.9 -<0.45 + S33 )Independent
405 2 2 171 - < 0.42 + 30.7 )Pyrimethamine
406 n,G — 122 - <0.86 + 30.2 )Res.
407 8 2 58.4 -<0.17 + 104 )(Parental
408 3 2 54.5 - <0.22 + 37.0 ) Type l)
409 o 2 56.6 -<0.22 + 52.1
\
)
410 k 2 211 -<0.24 + 46.3 )
411 C:o 3 116 - 0.31 + 38.6 )
412 3 3 216 - 0.26 + 99.8 )
413 3 3 34.7 - 0.10 -h 15.2 )
0(414 Ambi, 2 45.8 - <0.42 + 45.4 )
415 3 2 218 (3) - < 0.66 )Sulph. Sens.
416 G -2 10.0 @ - - < 0.11 )PAliA
417 3 2 12.5 © - - <0.15 )Dependent
418 3 2 301 @ - - < 1.05 )pyrinieth.
419 3 3 16.9 © - _ < 0.26 )lles. (Hon
&20 3 3 22S0 © — - <3.1 )Parental Type
421 c- 3 119 ® - - ( 0.27 ) 2)
422 2 3 < 0.66 - <0.48 + 48 )Su1phad. Sens.
423 2 C"<<G < 1.61 - <• 0.4:1 + 141 )PABA Independ.
424 O£2. 3 1.73 -<0.27 + 317 )pyi"imeth.
lOC\J 2 3 < 1.89 - < 1.89 + 134 )Sens.(Parental
426 2 3 <0.16 - < 0.16 + 14.2 )Type 2)
427 2 3 < 0.22 - < 0.22 + 137
\
)
428 2 3 <1.22 - < 0.83 + 8,0 \)
429 2 3 46.9 + 6.74 + 154 )Stilphad, Res.





























— 0.48 4- 38 First Parent
- 0.91 + 90 Sec, Parent
© normal PABA supplement
Qtj normal PABA supplement
+ reached peak
— failed, to grow
quantitative drug response presented in Table 24
clones 415-421 failed to grow on zero paba which
was used as a control for these estimates there¬
fore no estimates of jo growth was possible
(J) because of double enzyme type this line was recloned
and retested^LDH 2 6PGD 3)."
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sulphactiazine resistant and had arisen as a result of genetic
r e c ornbiaati on»
30 dilution clones were then established over a period of
time from the cross products and. each of these tested for its
responses to pyrimethamine (4 x 2.5 lag.kg *, normal PABA); to
_ i
sulphadiazine (4 x 1.25 rag,kg , zero PABA); and for their
ability to grow in the absence of a PABA supplement. Untreated
control mice were later sacrificed and their bloods freeze dried
and enzyme tested (LDH and 6PGD)» The results of these tests
have been summarised in Table 23.
Following consideration of the data a 4 way classification
was constructed comprising 2 parental types and 2 non parental
types, In order to further test the validity of this
classification, 7 clones were retested after Jan. 1975 and their
quantitative responses to sulphadiazine, to pyrimethamine and
their PaBA growth responses estimated: 1 clone representing each
parental category, 2 clones representing each non parental
category and CX 414 the presumptive double clone. These data
together with relevant comparison data have been summarised in
Table 24.
These data (in Table 24) were taken to confirm the
generation of two non parental classes of parasite phenotype
among the products of the cross. These seemed to most closely
resemble the two classes of mutant previously obtained by single
step selection using pyrimethamine and sulphadiazine■(or PABA
withdrawa1) - respectively.
Exploiting the rise in PABA dependencies after Jan. 1975 a
series of reconstruction experiments was undertaken whose
purpose was to measure the relative frequency of recombinant
parasites among the products of the cross and thereby estimate
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'l'iliil li'i 34
Cross 4; AJ v/ilcl type x As 9U3U1 ^Pyrimethamine resistant).
Responses to Pyrimethamine ana sulphacliazine ^u.5 gl PAuA
supplement) and. growth m the absence ot Fajba, {Data obtained
after Jan. 1975). Comparison data included.




AJ tiid type 0.93 ( U, 37 — 1. 10 ) 80.3 (57.3—126) -
AS 90391 34.5 (25.7-46.3) 37.2 (51.9-87.1) -
AJ 7032 3« id (1.58-2.91) 851 (372 -1947) +
AS pCi Df 19.1 ( 13.8—26.6) 3.35 (2.76-4.12) -
CX 414 0.03 (0.47—0.86) 08«8 (52.5-77.62) -
CX 401 45.4 (38.1—62.4) 57 ,5 (48.9—67.6) -
CX 420 20.4 (13.5—30.9) 3,64 (2.82—4.70) -
CX 421 17.2 (la.6—23.4) 3.60 (2.75—4•44) -
CX 42a 0.40 (0.28-0.57) 67 .6 (52,5-87.1) -
CX 429 1.41 (0.97-2.04) 204 (174 - 240) -f






the frequency of recombination between the genes proposed to
confer primary resistance to pyrimethamine and sulphauiazine.
To achieve this aim a series of dilutions was prepared
from the products of the cross and aliquots from these used to
inoculate 2 series of mice (C57 <?<?) receiving the full PABA
supplement (0.5 gl *), and no supplement. Control inocula were
prepared from parasites obtained from the biparental mixture.
The results of these tests are presented in Table 25.
TABLE 25
Cross 4; AJ wild type x AS 90301: Infectivity of 1 and 10
parasite inocula in the absence of PABA supplement. (Data
post Jan. 1975)
mean no, PABA Wo, Jo, sub— Poisson
Line parasites per supple, mice seq. Expect—
inoculum inocul. patently ation
infected





















Comparison of the number of patently infected animals in the
test groups with those expected on the basis of the Poisson
distribution (assuming 12.5fa of cross product parasites to be
PABA independent),showed no significant departures from that
expectation. This suggested that there was no detectable linkage
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between the genes proposed to control resistance to sulphadiazine
ana to pyrimethamine.
^iii) Analysis by examination^ of single oocysts obtained.
by microdissection: The parent lines used in Cross 4 proved to
be fertile despite multi blood passage (AS 90801 produced abundant
gametocytes and vigorous exflagellation even after some 100 serial
passages ). This and the fact Cross 4 had been analysed in the
greatest detail of all the crosses described in this study, led
to its choice for analysis by examination of single oocysts.
Bloods from both parents were harvested from splenectomised
rats on the fifth day after inoculation and the mixture adjusted
to contain equal number of exflageHating gametocytes from each
parent.
The mixed bloods were fed to cages of starved mosquitoes
using the membrane feeding apparatus already described.
Mosquitoes were dissected on or before the sixteenth day after
feeding and guts with ruptured oocysts discarded.
The remaining guts were then torn with sharpened tungsten
needles to yield fragments containing 1 or 2 oocysts; Mani¬
pulation was continued until isolated oocysts remained. Each of
these was removed in a pasteur pipette or on the end of a
tungsten needle to the first of the three depressions on the
water cooled slide and washed. After a second wash each oocyst
was ruptured in the third of these depressions and the resultant
sporozoite suspension injected into a stock mouse by the intra¬
venous route. Both the apparent maturity of the oocyst and the
ease with which the suspension was injected were noted. Control
mice were inoculated with the bulk of the second oocyst wash.
Out of 80 single oocysts injections, 13 were considered to
be 'good' injections of mature oocysts.
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Only 1 mouse inoculated with a single oocyst subsequently
became patently infected and that after 12 days. None of the
control mice became patently infected.
Enzyme electrophoresis showed this infection to possess
the variants peculiar to the sensitive parent only: (LDH 2
bPGI) 3). However subsequent tests shoved this infection to
contain parasites able to grow in the absence of a PABA
supplement, and so in all probability derived from a hybrid,
oocyst. Nevertheless, in view of the time taken for the infection
to become patent and more importantly, on the grounds of enzyme
monomorphism, the parasites were not further analysed.
The probable reason for the failure of this cross has been
briefly stated in the text of the discussion.
T'i
Cross 5: AJ 7032 (Sulphadiaziiie resistant) x AS P 1)W
(Pyrimethamine resistant). Cross conducted and analysed after
Jan. 1975. This cross, the reverse of cross 4, was performed to
show that multiple drug resistance may be generated by recombin¬
ation as well as being broken up by it.
(i) Origin of Parents: Both parent lines have been described
previously (AJ 7052, Table 8: AS P"- I)W Walliker et al., 1975); a
summary of their phenotypes has been included in Table 27,
(ii) Experimental details: The cross was performed after
Jan. 1975 by the modified crossing procedure using splenectomised
rats as rodent carriers of the mixed parental blood infection and
starved mosquitoes were permitted to feed on these rats on the
sixth day of infection: i.e. when the gametocytogenesis had
reached a maximum. These mosquitoes were starved a second time
15 days after the blood meal and allowed to feed on stock mice
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two days later. Patently infected mice were sacrificed and
exsanguinated and the bloods used to prepare samples for
electrophoresis,. The presence of both parental enzyme types
confirmed the transmission of both parents, 14 clones were
obtained from the products of the cross by dilution (0.25
parasites/inoculum). Each of these was tested for its ability
to grow at two PABA levels (0.025 gl * and zero PABA) and at
- 1 -Is
two doses of pyrimethamine (4 x 1.25 mg.kg and 4 x 40 rng.kg ).
Bloods harvested from control mice were subsequently used to
provide samples for electrophoresis. The results of these tests
have been summarised in Table 26, (Anomalous clones CX 507 and
513 were retested and these data used for classification). Two
clones CX 512 and CX 514 appeared to be non parental after the
preliminary tests and these clones were tested again and their
quantitative responses to pyrimethamine and sulphadiazine
estimated. These data together with relevant comparison data
have been summarised in Table 27. (The pyrimethamine response
of clone CX 512 was re—estimated after a second series of tests
and this figure is also included).
TABLE 26 - on accompanying page
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TALIiVi 26
Cross 5: AJ 7082 x AS I7"4, DW: Growth (expressed as a percent
of the control) of cross-product clones at two restrictive
EABA tests and at 2 pyrimethamine dose levels, (Data after





.025mg.kg Zero 1.25 40
clone CX501 + 32.7 + 14.7 28.0 (0.26 pr. i(ros,AJ 7 0 o2)
!! CX502 + 102 + 16.3 11.6 <0.11 11 ti
1? CX503 + 37.9 + 8.9 1.51 < .066 II 1!
H CX504 + 286 + 17 7 11.2 <0.45 11 11
!! CX505 + 44.2 + 2.80 13.6 < 0.20 11 f?
11 CX506 + 528 + 12.6 55.7 < 0.86 11 II
11 CX507* + 254 + 177 107 < 0.46 II 11
ft CX508 - < 0.14 — < 0.14 48.5 0.91 II (res.ASPri)Y/)
1? CX509 - < 0.11 - < 0.11 205 0.117 11 1!
II CX510 - < 0.12 - < 0,12 283 0.44 U 11
11 CX511 - <0.056 -<0,056 47.8 0.076 11 11
11 CX512 + 88.6 — < 0.22 65.0 54.3 npr. (res.AS90301)
II CX513* + 94.9 -<0.27 116 26.9 n 1!
n CX514 + 188 -<0.22 1.10 < 0.22 ii (res.AJ \y. tyjj
AJ 7032 + 7 o • 8 -I- 62.3 5,59 <0.16 - -
AS PP" I)1 - <0.18 - <0.18 45.2 1.78 - -
AS 90301 + 5,02 - < 0. 20 102 17.9 - -





npr = non parental
w. typ. = wiId type
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TABLE 27
Cross 5: AJ 7032 x AS PU DY/: Clones CX 512 and 514 responses
to pyrimethamine and sulphadiazine. Comparison data obtained
from both parents and AS 90501 and AJ wild type included.
(Data after Jan. 1975^ (All mice received the full PABA




























These data were taken to demonstrate that genetic recombination
had. generated both double mutant and wild type resembling
parasites and thus mimiced the reverse of the process thought
to have occurred in the case of Cross 4.
This cross has been further discussed in the text.
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Cross 6: AJ 7032 (Sulphadiazine resistant) x A3 rat adapted.
(i) Origin and characteristics of Parents; Both linos
have been described previously: A3 7032 (see Table 8 -p 54 }
A3 rat adapted (see .p 66 Table 15).
The aim of the cross was to establish the suitability of
one ran aaupoea marker x or use seiecoively in crosses with drug
resistance mutants; whether the inheritance of this character
was mendelian and if so whether polygenetic or not. An ideal
selective marker would have been inherited by a single gene;
(ii) Experiments1 detaiIs: This croS& tilf61/ S performed after
Jan. 1875 by the modified technique using splenectomised rats as
rodent carriers of the biparental mixed bloods. It was also
repeated using the membrane feeding apparatus with a blood
mixture containing parasites obtained from mice on or around the
tenth day of infection in the case of both parents. In both
cases the blood mixtures were adjusted to contain equal numbers
of gametocytes from each parent.
In both crosses sporozoites were harvested by allowing
infected mosquitoes to feed on stock mice. Parasites from these
mice were used to subino'culate both adult intact rats and mice
receiving no PABA supplement. Both groups of animal became
patently infected and this was taken to confirm biparental
transmission in the case of the cross performed using splenecto¬
mised rats as rodent carriers, but in the case of the cross
performed using the membrane feeding apparatus no rat adapted
parasites were detected.
In the successful cross a screening technique was employed
to detect recombination between the genetic elements controlling
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sulphadiazine resistance and adaptation to growth in rats. 8
newly weaned intact rats receiving no PABA supplement were each
inoculated with 10 parasites obtained from the cross product
bloods. Control animals, C57 mice receiving no 1AM. supplement
and aevly weaned intact rats receiving the normal PABA
supplement, received the same inoculum. Only the control
animals became infected.
Lest the rats provided a different PABA environment from
mice although preliminary evidence seemed to militate against
this the screen was repeated in a modified form. Thus parasites
harvested from the control mice in the first screen were used to
inoculate intact rats receiving a full PABA supplement. Different
groups of these rati were inoculated with & range of aliquots
2 4 6 ,
containing 10 *, 10' ancl 10 parasites. None of these became
patently infected.
This negative result was open to ambiguous interpretations
and these have been considered critically in the discussion




Reference to Table 1 which summarises the effects of
different PABA levels on the growth of wild type lines under
different conditions both before and after Jan. 1975, allows
two main conclusions to be drawn. Neither the supplementation
of the drinking water with prednisone (40 mg.l~~) nor the
substitution of a milk diet for the natural solid rat cake- had
any discernible effects on the PABA requirements of the wild
type parasites. While the first of these two tests was merely
a formal control for some of the selection experiments in which
prednisone was used as an immunosuppressive agent, the latter
suggests that at least after Jan. 1975 there were very few PABA
related compounds contained in the rat cake available for
parasite utilisation since it was known that milk diets are
deficient, in these (Hawking, 1958). This is specially relevant
in view of the major evidence summarised in Table 1 which
suggests that both wild type lines used in the present study
(AS and AJ) needed a PABA supplement of 0.025 gl * to reach peak
parasitaesaias after Jan. 1975 whereas prior to that date no such
supplement was necessary. That this finding was just as
applicable to the other lines used in this study for which data
are available can be seen from Table 28,
TABLE 28 - on accompanying page
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TABLE 28
Levels of minimum PABA supplements required for growth to peak
levels by wild type and resistant lines of P. chabaudi before
and after Jan, 1975. (All mice fed on rat cake).
line
minimum PABA supplement for growth to
peak (gl~f)
Before Jan. 1975 After Jan, 1975
AS wild type zero 0.025
AJ wiId type " "
AS # (1DW) 0.025 0.050
AJ 4027 " "
AJ 4028 " "
AJ 7031 zero zero
AS 90301 " 0.025
The sulphadiazine resistant line (AJ 7031) was evidently un¬
affected by the change whatever its cause - but this was only
to be expected in view of the association between PABA independ¬
ence and sulphadiazine resistance: the line maybe viewed as
being- so resistant as to be immune from minor fluctations in the
availability of PABA related compounds. Had curves of PABA
dependence against date of estimate been plotted for each of these
lines these would have all been flat with a step-up during the
period around Jan. 1975 - excepting the case of AJ 7031 whose plot
would have remained flat the whole time.
Since this upward quantum jump in PABA requirements affected
all lines to about the same extent - leaving aside AJ 7031 as a
special case — a common explanation was sought. Enzyme electro—
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phoresis ruled out the possibility of a mistake having occurred
and fresh and old supplies of PABA gave identical results, fiulti
passaged lines and lines which had recently been mosquito
passaged exhibited, identical PABA requirements so parasite ageing
was ruled out also and anyway this was not a common explanation.
The most plausible explanation was that the manufacturers
had knowingly or unwittingly allowed the composition of the rat
cake to have been changed — although direct enquiry was unable to
#®licit confirmation of this. Comparisons of the new rat cake
with milk diets were unable to detect any differences in the
ability to sustain parasite growth at a range of PABA levels
(Table 1). This suggested that the quantity of PABA related
compounds in the new rat cake was very low since milk diets are
known to be deficient in these (Hawking, 1953). Unfortunately
none of the old rat cake had remained for comparison, nor had
milk diet studies been carried out prior to Jan. 1975. Thus no
direct evidence of the hypothesis was available.
All estimates of sulphadiazine resistance obtained before
and after Jan. 1975 used mice receiving no PABA supplement.
Since after this date only sulphadiazine resistant lines were
able to grow under these conditions direct comparisons of the
responses.-of these lines only were possible. Thus, while the
ED for sulphadiazine was estimated to be 1.25 tag.kg ^ before
Jan. 1975, the estimate obtained after that date had dropped to
0.095 lag.kg-1 in the case of AJ 7 031. The quantitative nature
of the antagonism with su1phadiazine has been investigated by
Thurston (1954) and given this, the difference between these
two estimates would seem indirectly to have suggested that the
amount of PABA related compounds available to the parasites had
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diminished between the dates of the estimates.
Although the baseline responses of wild lines to
sulfadiazine (Table 2) agreed closely with those of Peters
(1967 ) the similarity was probably fortuitous in view of PABA
antagonism and the difficulty in standarising the level of PABA
supplementation between laboratories. The dramatic increase in
baseline estimates of sulphodiazine resistance after Jan. 1975
merely reflected the increased level of PABA supplementation
occasioned by the inability of most lines to grow in the absence
of this compound.
Reference to the baseline pyrimethamine response data
summarised in Table 3 shows that here too, resistance seemed to
be related to the size of the PABA supplement but the relation¬
ship would seem to have been less straightforwardly competitive
than that reported by Thurston for sulpliadiazine. It has been
shown graphically in the case of an AJ wild type line in Fig. 5.
Thus while raising the PABA supplement from zero to O.OSgl *
effectively increased the resistance of this line some sixfold
further increases in the level of the PABA supplement up to
— 1
l.Ogl had no effect or sensitivity. (This type of saturation
curve was also found in the case of AS 90301, the doubly
resistant mutant line.).
It is possible that the discrepancy in base line sensitivity
estimates in P.chabaudi between those of the present author and
those of Peters (1967 ) (his line was some 15 times more
sensitive) may to some extent be accounted for by the routine
use of rather high levels of PABA supplement in this laboratory.
This may not be such a bad thing since it follows from the fore¬
going-discussion that more reproducible estimates of drug
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resistance will be obtained in the region of PABA levels
encompassed by the flat part of the pyrimethamine response/PABA
level curve since these will be less labile to minor fluctuations
in PABA supply such as might be expected between batches of rat
cake and further aggravated by the tendency of animals to vary
their intake of food and water, (Another reason for maintaining
animals on high level PABA regimes is to avoid unwanted
selections for sulphadiazine resistance,) On the other hand it
is clearly preferable to obtain estimates of sulphadiazine
sensitivity without any PABA supplement since total restriction
probably offers the best means of maintaining a constant supply
of this substance that is, if the parasites will grow under these
conditions.
The close correspondence between estimates of pyrimethamine
sensitivity obtained before and after Jan, 1S75 (Table 3) is un¬
remarkable, From consideration of the pyrimethamine sensitivity/
PABA level curve it follows that the removal of 0.025 gl ^
equivalent—PABA (the probable size of the PABA deficit in the
new rat cake) would not shift the amount of residual PABA off
the flat part of the curve and would, therefore be unlikely to
affect pyrimethamine sensitivity.
Finally, the data in Table 3 demonstrate that the A3 and AJ
wild type lines were indistinguisable on the basis of their
responses to sulphadiazine and to pyrimethamine: i.e. there was
no evidence of wild resistance to these drugs or that either had
acquired resistance inadvertently such as by PABA restriction.
This was a subtly important result since it implied genetic
uniformity - a vital factor if these lines were to be used in
crosses together or to be compared in selection experiments.
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2. Selection Experiments:
Table 4 summarises the results of the pyrimethamine
selection experiments all of which were carried out before the
PABA shift in Jan. 1975.
Two types of experiment were performed as judged by the
intensity and prolongation of drug pressure: experiments 401
to 407 inolved the use of short-term, high-dose therapy whereas
in those numbered 409 to 415 a lower close was used and therapy
maintained till the emergence of recrudescent lines or 20 days
whichever was sooner. (Control studies showed that no
recrudescent lines emerged after this time suggesting the
complete elimination of parasites.) Experiment 408.intermediate
in character between these two classes, was designed to facilitate
comparisons between them. The results of the preliminary tests
performed on recrudescent lines following selection have been
presented in Table 5. More rigorous quantitive drug responses
and PABA dependences have been summarised for some of these lines
in Table G. While the latter data were used in drawing up the
basis of a classification the preliminary data in Table 5 were
used in classifying these lines where no further tests were
performed. Thus the numbers of lines scored were enlarged, for
statistical reasons when calculating frequency estimates. (This
procedure has been followed in all the selection experiments in
this study.)
Recrudescent lines following pyrimethamine selection were
divided into two main classes on the basis of these responses:
resistant lines which resembled AS P DW; and sensitive lines
which were indistinguishable from wild types. The line AJ 4139
was considered to be anomalous i.e. fitting into neither of these
1
categories. bince further tests revealed this line to be
sulphatiiazine resistant (see Table 0) it has been discussed
along with the other sulphadiazine resistant lines later on in
this section. The sensitive lines were considered to consist
of wild parasites which had survived selection for any reason
and were not further investigated.
All the so-called pyrimethamine resistant lines were
obtained following direct exposure to the drug. They were
characteristically about 19 times resistant to pyrimethamine:
the mean £Dgg (n = 9) was lb.41 ( + ISE range 14.61 to 18.48 rug.
kg ). They were about 0.04 times resistant to sulfadiazine
(O.Sgl PABA supplement, after Jan. 1975) though too few
estimates were made to attach a range to this figure. All of
these lines required a dietary PABA supplement to reach peak
growth: the supplements being 0.025gl * before Jan. 1975 and
-1
0.05gl after this date. In this last respect they may be saicl
to have resembled the lines described by Jacobs (1964) in
P.berghei; and in P.yoelii by Morgan (1974) which she termed
17 x Hil. Thus the resistant lines formed a fairly homogeneous
group ana this phenotypic similarity was taken to be suggestive
of genotypic similarity. Although it is tempting to invoke the
absence of lines intermediate in character between these
resistant lines and the sensitives as strong evidence tliat a
point-mutation was responsible for conferring pyrimethamine
resistance both the imprecision of drug tests and the possibilit;
that the modes of selection imposed a "procrustean bed" on the
types surviving drug pressure, cannot be ruled out. However
such genetic evidence as was available (see crosses 1 and £) was
also in favour of the single gene hypothesis and for the purpose
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calculating acquisition rates this hypothesis was taken as given.
As drug dosage increased while the frequency of
recrudescence decreased, the proportion of resistant lines
among them increased (see Table 4). This was expected and leads
to the notion of an optimum selection pressure for estimating
acquisition rates. In the case of the short-term, high-dose
experiments this ideal was most closely approached in those
-1
experiments where 4 closes of 50 rag.kg were administered; and
in the case of the continuous dose experiments by those in which
5 or 10 mg.kg were administered. By confin: ing frequency
-11
estimates to these regimes this was found to be 1.66 x 10 in
the case of the short-term, high—dose experiments - agreeing
-11
very closely with the figureof 1.59 x 10 obtained by Morgan
(1974), However the estimate obtained from the continuous dose
— 10
experiments was some six times more frequent at 1.06 x 10
The reason for this discrepancy probably lay in the use of
such high close regimes themselves under which even resistant
parasites were probably not immune from damage and that
sustained just at the time when numerically they were most
susceptible to chance elimination (see Martin.aiuL Arnold 1968).
In contrast the continuous dose regimes can be plausibly
pictured as imposing a drug pressure which, while sufficient to
gradually eliminate sensitive parasites, would have imposed
only the mildest of restraints on the multiplication of
resistant parasites.
Moving on to the experiments in which pyrimethamine was
administered to animals receiving no PABA supplement (Table 4,
expts. 403 and 4-11) it may be seen that no parasites of any
sort survived such treatment. These results were not unexpected
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in view of the pyrimethamine hypersensitivity induced by PABA
restriction (see Table 3 and Fig. 5} and the inability of
pyrimethamine resistant lines to grow in the absence of PABA.
In expts. 403 and 4-04 it had been hoped to accelerate the
development of resistance to pyrimethamine by immunosuppression
either using the steroid prednisone administered in the drinking
water or by splenectomy. (Care had to be exercised in the choice
of mice for these experiments since it was found that other than
SPF mice tended to become sick after exposure to prednisone
presumably on account of the consequent liberation of subpatent
non pathogenic infections by organisms of unknown origin.) In
fact a result opposite to that hoped for was obtained and only
one resistant line was thus obtained corresponding to a rate of
-12
5.7 x 10 . On the other hand many more sensitives seemed to
survive drug treatment than had been the case without immuno-
-11
suppression (5.1 x 10 (data from splenectomy and prednisone
treatment pooled) as opposed to 0.47 x 10 ^ (no immuno¬
suppression)). This was taken to support the view that drug
treatment may act in concert with host immunity in eliminating
parasites during selection. Since the response of parasites to
pyrimethamine seemed unaffected by the presence of prednisone
(Table 3) the most likely explanation for its effect of re¬
versing the ratio of sensitives to resistants when used in
selection experiments is that this co-operation between the
drug and the hosts immune system is synergistic. Thus, while
normally we may picture the hosts immune system picking out the
more damaged sensitive parasites, but unable to affect the less
damaged resistant ones after heavy drug treatment, no such
discriminatory mechanism would be operable under
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imtaunosuppression thus allowing time for these sensitive para¬
sites to convalesce. This is really equivalent to stating than
in the present case immunosuppression defeated its otto purpose.
Alternatively, though perhaps less plausibly, one might
explain the apparent deficiency of resistant parasites by stating
that their appearance had been merely masked by a majority of
sensitive parasites. There are two main objections to this
proposal however. Firstly, such evidence as was available from
drug tests suggested that such a numerical superiority would have
had to have been overwhelming (in the order of about 10 to 1) to
disguise the presence of resistant parasites. Secondly, such an
explanation would have had to have taken into account the
assumed coincident recrudescence of sensitive parasites and the
resistant parasites supposedly masked by them.
Immunosuppression has..been used to promote the acquisition
of drug resistance in Trypanosomes. Following the pioneer
efforts of Jansco and Jansco (1984), Schnitzer et al.(1946)
obtained a higher rate of P-rosaniline resistance in T.equiperdum
after splenectomising the rodent hosts. More recently, Hawking
and his co—workers (Hawking, 1966, Hawking and damage, 1967)
obtained resistance to chloroquine in B.berghei following
immunosuppression effected by injections of ethyl paImitate;
however their data were insufficient to say whether this rate was
any higher than would have been the case without immunosuppression*
The details of the. sulphadiazine selection experiments have
been summarised in Table 7 and the characteristics of the
resistant lines so obtained, have been summarised in Table 8.
For ease of comparison only the response data obtained after Jan.
i-975 nave been included. Lines 70ol to 7086 were obtained by
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direct exposure to the drug bet'ore Jan. 1975 and lines 8015 to
8017 by PAHA wi theiraural after that date when it had become an
absolute requirement for the growth of ft'ild type lines. it
was impossibie to identify the mode of selection used to obtain
resistant lines either on the basis of their responses to
su1phadiazine or to pyrimethamine as both of these characters
appeared to vary continuously. To what extent this was merely
due to the imprecisions of the tests used, remains unknown.
Thus pooling all data the sulphadiazine resistant lines'
(n = 8) were 3.80 times resistant to suiphadiazine: EDr~ = 305.1
-1,
( + 18E range, 254.2 to 866.1 sag.kg ). None required PABA for
growth either before or after Jan. 1975. Line AJ 4139, the so
called anomalous line obtained after exposure to pyrimethamine
-1
(2.5 sag.kg continuously) had a similar response to suiphadia¬
zine : ED,,., = 478 (+ ISE range 274 to 619 rag.kg *) and needed no
PABA supplement either. Its ED„„ for pyrimethamine of 2.4-8 (+JJ """"
ISE range 1.81 to 6.59 rag.kg while significantly higher than
that of sensitive lines was indistinguishable from those of the
suiphadiazine resistant lines whose mean ED, _ was 1.68 H- ISE90 —
— 1
range 1.4-8 to 1.91 rag.kg ). Though as a group this was just
significantly higher than that of the wild types, individuals
were in some instances not so distinguishable. Morgan (1974)
also reported an instance where a suiphadiazine resistant line
had been selected indirectly in this way. There seemed to be
uo greater cross resistance to pyrimethamine exhibited by lines
obtained by direct exposure to the drug than those obtained by
PABA restriction which contrasts with the findings of Novell
(1970, 1972) in the case of P.berghei. Nor was there any
evidence that cross—resistance wo pyrimethamine had manifested
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itself prior to the expression of the primary resistance itself
(Bishop and filcC onnachie, 1950c) though the experimental
conditions "were not really conducive to recognising such a
phenomenon.
Although it Tiiis impossible to further classify the
sulpiradiazine resistant lines on the basis of their responses
to pyrimethamine, it was far less certain than in the case of
the pyrimethamine resistant lines that they formed a homogeneous
category; and although the acquisition frequency estimates have
ignored such a possible heterogeneity this caveat should be borne
in mind. (in fact, evidence presented in the next section on
selection experiments using mutant lines would appear to support
the notion of at least two classes of sulphadiazine resistant
mutant.)
Among the sulphadiazine selection experiments described in
Table 7, the optima for obtaining acquisition frequency estimates
were judged to be found in the case of the short term, high dose
x
experiments in those in which 4 doses of 2.5 or 5 wg.kg were
adrninistered. The pooled acquisition esuima'oe from these was
3.5 x 1Q~^„ The PAEA withdrawal experiments yieideu. a rate of
i.34 x 10^ which rose without statistical significance to 2.03
x 1010 when prednisone was administered in the drinking water as
an immunosuppressive.
In short therefore, all these variemes of selective
treatment had succeeded in producing only two classes of
resistant parasite: pyrimethamine resistant with an increased
dependence on PAEA; and sulphadiazine resistant with a reduced
dependence on this compound. In addition it was found that
continuous selection pressure maintained until the emergence of
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recrudescent lines was the most efficient means of producing
resistant lines of parasite. The significance of this in
calculating true mutation rates will be considered in the
genera1 discussion.
3. Selection Experiments Using Mutant Lines:
In Tables 9-12 are summarised the results of selection
experiments involving the withdrawal of PABA from PABA dependent
pyrimethamine resistant lines. Expts. 901 and 902 were performed
before Jan. 1975 and expt. 904 was performed after that date.
As has already been noted, the PABA requirement of pyrimethamine
-1 -1
resistant lines doubled from 0.025 mg.kg to 0.05 mg.kg after
Jan, 1975 and the selection pressure imposed by removal of PABA
way be regarded as having been correspondingly intensified.
Thus the failure to obtain recrudescent lines after that date was
not unexpected. In the experiments performed prior to the
increase in PABA requirements, all recrudescent lines tested
proved to have regained independence from PABA without loss of
pyrimethamine resistance (n = 44). It had been hoped to isolate
wild type revertant parasites in this way and their absence from
among those recrudescent lines characterised suggested that the
reversion rate for pyrimethamine resistance was very low.
On the contrary PABA independence had been accompanied by a
further increase of pyrimethamine resistance amounting to some
1.7 times that of the line subjected to continued selection
(with a range from 0.06 to 2.74). The mean EDgo for the seven
'lines tested was 32.98 mg.kg * (+ ISE range 28.43 - 38.26 mg.kg' ).
This continuuwi o{cross resistance closely paralleled that observed
among the recrudescent lines isolated after PABA withdrawal and
1
sulphadiazine selection of wild type lines. It seemed likely
therefore that the result of PABA withdrawal had been to
superimpose a second genetic change which on its own would have
conferred sulphadiazine resistance. However the pre-existing
PABA independence had so to speak cancelled out this
sulphadiazine resistance. In fact,. when the responses to
sulphadiazine of one of these lines (AS 90801) was compared with
those of a wild type line, very little difference was to be
observed (see Table 22) and this supposition was later confirmed
genetically (see crosses 4 and 5).
The rate of acquisition of this resistance as obtained from
—*10
expt. 901 was 1.9 x 10 agreeing closely with the rate observed
with the wild genetic background. The rate after immuno—
£0
suppression was not significantly altered at 1.85 x 10 , again
resembling the result obtained from the wild type selection
experiments. However these results do not necessarily prove that
there were no immune factors operative which might have reduced
the observed rate of resistance acquisition to below that of true
mutation rate. Furthermore, though all the recrudescent lines
were homogeneous with regard to their responses to sulphadiazine
or PABA, this does not necessarily imply genetic homogeneity.
The extent of the range of cross resistances to pyrimethamine was
some threefold and random errors might have disguised the
presence of two or more classes of mutant.
In Tables 12 and 13 are summarised the results of selection
experiments carried out after Jan. 1975 in which AJ 7032 which
had already been made resistant to sulphadiazine by direct
exposure to the drug (4 x 5 mg.kg * with no PABA supplement -
before Jan. 1975) was subjected to continuous pyrimethamine
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therapy for up to 20 days at doses of 10, 20 or 40 mg.kg-1.
This line had acquired a twofold cross resistance to pyrimethamine
(EDgo = 2.19 rag.kg *) simultaneously with being made
sulphadiazine resistant and was of course PABA independent both
before and after Jan. 1975.
Uecrudescent infections were only detected in the animals
which received 10 or 20 rag.kg * of pyrimethamine. These arose
at rates of 1.0 x 10 at both levels of drug pressure i.e. not
significantly different from the rates of recrudescence when
wild parasites were subjected to continuous drug pressure with
pyrimethamine at the correspondingly lower doses of 10 and 5
rag.kg. Thus as was the case with the acquisition of sulphadiazine
resistance following PABA restriction the presence of the
allele conferring resistance to the other drug did not appear to
have any effect on the rate at which resistance was acquired.
Classification of recrudescences was based on the
qualitative -information obtained from abbreviated 4 day tests
— 1
using pyrimethamine (4 x 20 tag.kg ) a dose sufficient to
suppress infections of AJ 7082 (the line which originally under¬
went selection) and from PABA tests. All the recrudescent lines
produced patent infections at that dose of pyrimethamine - but
none were able to grow in the absence of PABA whereas the
ancestral line could.
As a cross check one line (AJ 12021) was retested and its
quantitative response to pyrimethamine estimated: (EDg^ =
-1 -1-
81.62 mg.kg + ISE range 28.44 - 42.66 mg.kg )» Thus both
in the respects of pyrimethamine resistance and of PABA
dependence it closely resembled the series of lines obtained
from AS P"1 DW after PABA restriction. It was concluded that
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both types of selection had led to the superimposition of
pyrimethamine and sulphadiazine resistance. These had inter¬
acted in predictable though interesting ways: firstly, it had
appeared that the rather high levels of pyrimethamine resistance
exhibited by these double mutant lines were the result of the
geometric summation of primary pyrimethamine resistance and the
cross resistance to pyrimethamine concomitant with primary
sulphadiazine resistance. Conversely the increased PABA
dependence following primary resistance to pyrimethamine appeared
to have been cancelled out by the acquisition of sulphadiazine
resistance so that these double mutant lines were indistinguish¬
able from wild types on this criterion alone.
Although, as has already been mentioned, it had been hoped
to use cross resistance to pyrimethamine as a diagnostic
character: in the classification of sulphadiazine resistant lines,
the rather wide spread of these made this impossible with the
tests available. (The standard errors attached to these
estimates routinely encompassed a twofold range of resistance
alone.) If the significant differences between the extreme
limits of resistance were real rather than due to error then this
meant that sulphadiazine resistance mutants were heterogeneous
and might be superimposed by repeated selection,. Certainly, the
levels of sulphadiazine resistance observed in the present study
ranging from 2 to twelve-fold had been greatly exceeded by
Jaswant Singh et al. (1954), suggesting that continued selection
might foe successful. If continued selection increased the level
of sulphadiazine resistance this would show that these mutants
were indeed heterogeneous unlike the case observed with
pyrimethamine resistant lines.
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This selection experiment was facilitated by the increase
in PABA dependencies after Jan. 1975 since double mutant lines
such as AS 90501 were unable to grow without a PADA supplement
after that date and could therefore be selected using PABA
restriction. This turned out to be a case of killing two birds
with one stone: the attempt described previously to isolate
wild type revertants (i.e. back mutants) from single step
pyrimethamine resistance mutants by PABA restriction had been
foiled by the intervention of superimposed sulfadiazine ■
resistance. Since the double mutant already had one of these
sulfadiazine resistance mutants, only the availability of more
of these could allow the attempt to fail again.
The result of the experiment confirmed the heterogeneity
hypothesis and has been summarised in Table 14, all 4
recrudescent lines uiwnougu now PaBa inuepencenx. and therefore
presumably sulphadiazine resistant, had experienced no
perceptible alteration in the level of their responses to
pyrimethamine: mean ED__ = oo.B nig.kg ( ohe estimates rangingdU
-1- -1
from hS.5 to 4k,.4 mg.kg ) compared to 34,5 rag.kg for the
ancestral line.
The rate at which this resistance was acquired was 1.8 x
— X 010" — not significantly different from any of the other
estimates obtained after PABA restriction - though the numbers
were low.
These data were taken to show that at least two different
types of mutant conferring sulfadiazine resistance existed but
failed to demonstrate the occurrence of "back-mutation."
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4„ Eat Adaptation:
Foiloving Coombs and Gutteridge (1975) rat adaptation was
effected by repeated passage in splenectomised and intact, newly
weaned rats„
Table 15 summarises the growth characteristics of wild and
rat adapted lines in rats and mice as well as their principal
drug responses before and after selection.
As was expected neither pyrimethamine resistance nor PABA
dependence was significantly altered by rat adaptation and these
tests were performed as formal controls since it had been planned
to use the rat adapted line in crosses.
(Although in a thorough study of rat adaptation it would have
been desirable, no samples were retained from infections
observed, during the course of the selective passages. Has this
been done a graph of rat growth could have heen plotted against
number of rat passages. However since the main aim of the
research was the study of drug resistance the obtention of a rat
adapted line was regarded as peripheral.)
wei t.u«r of hue wild P. chabaucli lines used in the present
study were able to grow in intact rats whether newly weaned or
adult. Growth of these lines in newly weaned splenectomised
rats was erratic but it appeared that the AJ line had the edge
over AJ in this respect. (AS also reached higher peak
parasituemias and was more virulent than AJ in mice as the data
in Table 15 show.) It was felt that in view of its slightly
poorer growth in rats AJ was a better baseline from which to
commence selection and all the rat adaptation experiments used
this line.
The principal consequence of selection was to permit the
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growth of this AJ line in intact rats and to show this
ability was stable after mouse and mosquito passage, Although
y;„rasitaemias rarely exceeded 10/fa in adult (S weeks) rats,
figures of 20 to '60%< were common among those newly weaned.
These were therefore somewhat lower than the figure of 85cjo
which Coombs et al.(1975) mentioned in connection with their
line. They also noted the loss of the ability to produce
gametocytes after adaptation but did not say how many passages
their line had undergone so it was impossible to say whether
this was a- consequence of adaptation or multi-passage. In the
present study no such total lossof gametocytogenesis was observed
and although the adapted line was no less fertile in rats than a
wild line in mice would have been many fewer gametocytes were
produced than in a wild line in intact or splenectomised rats.
Thus, if looked at it this way, during adaptation a gradual
decline in gametocyte producing potential had taken place.
Thus while a wild line growing in splenectomised rats (or
subsisting in young intact rats after a large inoculum) would
routinely produce an infection comprising about 80/fc gametocytes
the adapted line rarely exceeded 10/| in any host.
(As has been noted this enhancement of game t ocyt ogenesis
observed among non-adapted lines was exploited to facilitate
crossing.)
Although this host specificity might have resembled the
case of Duffy antigens in preventing the invasion of erythrocytes
by P.. Enowlesi (Miller et al., 1975) this fails to account for
the enhancement of game tocytogenesis in wild lines. PABA
deficiency had been ruled out as a cause of the latter phenomenon
since the administration of excess quantities of PABA failed to
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affect tire process. Nor had the administration of sulphadiazine
been shorvn to increase garnetocytogensis unlike the case reported
by Bishop (1954a). Whatever the mechanism it appeared to
operate as a positive stimulus since selection favouring the
survival of gametocytes could not alone account for their
abundance given the numbers of trophozoites and schizonts
observed during the cycles of these infections.
Thus the most plausible explanation was that host immunity
had been responsible both for the enhanced gametocytogenesis in
wild lines and for the mechanism of host specificity in rats.
Certainly the effects of splenectomy in encouraging the growth
of wild parasites in rats was consistent with this hypothesis,
but unfortunately attempts to investigate the effects of host
immunity and erythrocyte barrier mechanisms failed due to
technical reasons but the recent development of a successful
semi—in—vitro technic,ue for the continuous culture of plasmodia
(Trager et_al., 1976; Haynes et al., 1976) offers some
encouragement in this direction.
Whether or not an immune trigger is necessary for ganeto-
cytogenesis remains doubtful: although the process occurs late
in P.chabaudi in mice — after the time of peak fertility — the
opposite is true in p.yoelii.
If the host specificity could be shown to reside in host
immunity rat adapted lines could provide an interesting example
of antigenic variation'in plasmodia. The correlation of the
degree of adaptation with such hypothetical variants would be
specially amenable to genetic analysis augmented by the use of
the continuous culture techniques referred to above.
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^ * I'h® Crosses:
Cross 1 — lialliker et e.1. (1975) demonstrated free re—
combination between markers conferring resistance to pyrime¬
thamine and variants of the enzymes LDII and 6PGB. Dr. 'Walliker
was kind enough to permit further analysis of the products of
this cross with a view to finding- out whether any segregation
had taken place between the pyrimethamine resistance marker he
used and the PABA dependence which had accompanied its original
selection by direct exposure to the drug (4 x 50 mg.kg"1). A
screening technique was used rather than the normal method of
scoring clones since the latter method was unsuitable for
detecting rare events.
Although the precise number of oocysts contributing
sporozoites to the initiation of the cross product blood
infection remained unknown,~in view of the abundance of oocysts
observed on the mosquito guts of that cross (Dr. I). Walliker
pers. comm.) these probably numbered several hundreds. More¬
over the frequency of recombinant clones reported in that cross
(Walliker et al., 1975) was not significantly different from
that expected to have arisen from an oocyst population of which
50fc had been hybrid - the maximum possible frequency obtaining
if the original blood mixture had included equal numbers of
gametocytes from each product. (See Fig. 4 again for a
graphical explanation of this point, if necessary.)
Double selection, by exposure to pyrimethamine to remove
the sensitive parent and by withdrawal of PABA to remove the
resistant parent, failed to reveal the presence of any parasites
belonging to the hypothetical non-parental class in which
resistance to pyrimethamine was accompanied by a normal wild type
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PABA dependence. (As the cross was performed 'before Jan. 1975
this dependence was zeroJ Thus recombination had failed to
split pyrimethamine resistance from its concomitant EABA
dependence and it seemed much more likely that pleiotropy had
been responsible for this association of characters. This
conclusion was also consistent with the predominance of this
class-of pyrimethamine resistant mutant in this study (see Table
5 ) and in that of Morgan (1974) both following single step
selection. It was unlikely that these two characters should
have been so consistently found together if separately inherited
unless the mode of selection had been conducive to this. There
was no obvious reason why this should be so and on the contrary,
the single step method was judged to favour the selection of
point mutations. In short, this pleiotropic phenotype was
considered the expression of a genetic "elementary particle" of
pyrimethamine resistance though not necessarily the only one.
If this were so then the 9 pyrimethamine resistant lines
whose detailed characterisation had revealed an increased level
of PABA dependence (see Table 6) had arisen as a result of
mutation in the same gene. In order to test this proposition,
the series of crosses presented under the heading "cross 2" were
carried out (see results). The three possible types of pairwise
cross were performed between the three independently isolated
lines, AJ 4027, AJ 4028 and AS P1" BV; described in Table 18.
(The last of these lines had been used in the cross reported by
Br. D. WaHiker ('Walliker et al., 1975) and had been selected by
him. All had been made resistant to pyrimethamine by direct
exposure to the drug in a single step and were unable to grow in
the absence of PABA when the experiment was performed before Jan.
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1975.
The analysis of these crosses again made use of a
screening technique to detect rare recombinants. This consisted
of passaging the three pairs of crossproduct bloods through mice
receiving no PABA supplements. Even the largest inoculum size
used (10 ) failed to induce patent parasitaemias in PABA free
mice. (Larger inocula were not used for two reasons: firstly,
these might have permitted spontaneous mutants to be scored as
putative recombinants; also it was considered rather pointless
in view of the probable sizes of the 3 hybrid oocyst populations
which had contributed to the cross product blood parasites.
jC cA
These were unlikely to Lave each exceeded 10 ; and 10 was
reckoned to be the most likely figure for the number of hybrid
oocysts as judged from examination of mosquito guts and from
consideration of the time delay between sporozoite inoculation
and the appearance of patent blood infections.)
The failure of these crosses to produce PABA independent
parasites was taken to suggest that the mutations in each of
these parental resistant lines were very closely linked indeed.
The upper limit of recombination frequencies in any of the
pairwise crosses was set at 0.3^. This, together with the
phenotypic similarity between these lines suggested in each case
the mutation conferring resistance had probably occurred within
the same gene.
Had PABA independent parasites been detected the most
probable explanation for their appearance would have been as a
consequence of a genetic recombination event generating wild
type parasites. This process has been illustrated in Pig. 7.
117
FIG, 7
Model of recombination, to generate wild types from cross between

















ml = mutation in first parent
ru2 = mutation in second parent
+ = wild allele
Reciprocal genetic exchange would also in this case have
been expected to generate a completely new genotype with both
the mutant alleles from the parents. (The phenotype of this
recombinant woulu have been a matter for conjecture and it
remained a possibility that the combination of both mutant alleles
would have been lethal and therefore undetectable.)
It was not possible to pursue the analysis of the
inheritance of sulphadiazine resistance as far as had been
achieved in the case of pyrimethamine resistance. The main
reason for this lay in the non availability of screening
techniques and prompted the development of other screening
techniques utilising the selective marker conferring rat adaptation.
Cross 8 (see results) was analagous to the cross reported by
Walliker et al., (1975) with the substitution of sulphadiazine
resistance for resistance to pyrimethamine. This sulphadiazine
resistant line was crossed with a wild type line.
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As the cross was carried out and analysed after Jan. 1975,
only the sulphadiazine resistant parent could grow in the
absence of a PABA supplement. Consequently, growth in the
absence of PABA was used as the primary diagnostic character
in the dichotomous classification of the cross—product clones.
The details of these PABA tests have been summarised in Table
21. In addition abbreviated 4 day tests were used to estimate
the growth percentage of each clone after sulphadiazine
- -li
treatment (4 x 160 nig.kg ) and pyrimethamine treatment (4 x
-1\1.25 nig.kg ) - both drugs being administered to mice receiving
-1
the normal PABA supplement of 0.5 gl
The dichotomous classification based on the all or none
PABA test data was substantially confirmed in the case of the
responses to sulphadiazine which with a mean growth percentage
of 124.4$ (+ ISE 108 - 150} for growers were significantly higher
than the mean percentage for non-growers of 1.80$ (+ ISE 1.24 -
2.62) with no overlap. On the other hand there was a slight
overlap when growth after pyrimethamine therapy was measured -
but the zero pafoa growers mean percentage of 50.0 (+ ISE 26.8 —
98.4) was still significantly higher than that of the non-
growers at 1,22$. The overlap in pyrimethamine resistance how¬
ever was expected in the light of the rather small difference in
resistance between the parents - the resistant parent being
only about twice as resistant as the sensitive parent at the
E1)q„ level. In fact it was surprising that the overlap had notJ\J
been greater.
As Walliker et al. (1975) had reported in the case of
pyrimethamine resistance there appeared to be free recombination
between the marker conferring resistance to sulphadiazine and
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the two enzyme markers (LBH and 6PGI)) .
Although there was no evidence that the marker conferring
sulfadiazine resistance had segregated polygenically, caution
has to be observed in interpreting this result. Due to the
crossing system which permitted incestuous matings to take place
between micro and macrogametes within each parental line, at
least and probably about 50jis> of all clones would not have been
given the opportunity to undergo recombination and would there¬
fore have exhibited their parental phenotypes anyway. The.
scoring bias thus incurred would have had the tendency to pull
the mean growth percentages towards their respective parental
means and possibly disguised any evidence of polygenic
segregation. The number of clones scored was too few to have
permitted an adequate statistical correction of this bias.
Nevertheless, given this caveat the evidence from the clone
characterisations was not inconsistent with a single gene model.
The evidence was as good as could have been hoped for in the
circumstances. Although it was not the main purpose of the
experiment to test the hypothesis, the data showed no evidence
of independent segregation of the primary resistance to
sulphadiazine and the pyrimethamine cross resistance. Again
the caveat mentioned above should be noted in this connection.
In Cross 4 (Tables 22-25) a wild type A3 line was crossed
with the presumptive double mutant AS 90301 which had received
two bouts of selection:- firstly by direct exposure to pyrime¬
thamine (4 x 50 sag.kg-^; Walliker et al. , 1975) and then by
PABA restriction (both before Jan. 1975).
30 clones were briefly characterised before Jan. 1975 and
a further more detailed characterisation were performed on seven
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of these lines, thought to represent the 4 resistance phenotypic
classes encountered in the cross, after that date.
In tlie preliminary tests as well as in the enzyme typing
(L'DH and oPGDj three characters were measured for each of these
30 clones: growth in the absence of a PABA supplement; growth
after sulphadiazine treatment (4 x 1.25 mg.kg , without a PABA
supplement); and growth after pyrimethamine treatment (4 x 2.5
mg.kg , with the normal PABA supplement of 0.5 gl x). Growth
in these tests was measured in two ways: both as a percentage
of the untreated control and qualitatively - whether or not
patent parasitaemias were observed in the group experimental
mice receiving each treatment. Due to the rather large
variations in the quantitative measurements of pyrimethamine
resistance the classification into 4 types was in the main based
on the responses to sulphadiazine and on the measurements of PABA
dependence.
The 4 phenotypes observed were as follows (see Table 23):
1. Growth unaffected by pyrimethamine; growth abolised
by sulphadiazine and growth unaffected by withdraw1 of PABA.
(Clones CX4-01 - 414; parental type 1).
2. Growth unaffected by pyrimethamine j growth abolished
by sulphadiazine and growth abolished by withdrawal of PABA.
(Clones CX4-15 - 421: non-parental type 2).
3. Growth abolished or nearly abolished by pyrimethamine}
growth abolished by sulphadiazine and growth unaffected by
withdrawal of PABA. (Clones CX422 - 423: parental type 2).
4. Growth variably affected by pyrimethamine; growth
only slightly affected by sulphadiazine and growth unaffected
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by the withdrawal of 1JABA. (Clones 429 — 430, non—parental
type 1).
Following the PABA shift in Jan. 1975 seven clones were
tested in more detail and their responses to sulphadiazine and
to pyrimethamine have been summarised in Table 24 together "with
their updated PABA growth responses. Comparison of these
responses with those of the parents and the two single step
P
resistant lines AJ 7031 (sulphadiazine resistant) and AS I WS
(pyrimethamine resistant) permitted the following similarities
to be noticed: between AJ wild type and clones CX414 and CX422;
between AS 90301 (the double mutant resistant parent) and clones
CX401; between AJ 7031 and clones CX429 and CX430 (non parental
class' 1) jand between AS BE BW and clones CX420 and CX4.2.1 (non
parental class 2).
(Clone CX414 had originally been classed along with clone
CX4-01 but following the discovery of a double LBH band it was
recloned and reverted to a wild phenotype. This illustrated one
of the hazards of cloning by dilution and underlined the value
of enzyme typing in genetic studies, of clone phenotypes.
Presumably, the original "clone" had comprised two types of
parasite; a pyrimethamine resistant type as well as the wild,
type later identified. Since drug resistance was "dominant" to
sensitivity the wild parasites were not detected in the original
series of tests.)
The occurrence of non parental parasites with phenotypes
resembling tnose o± single step mutants rGsisomro to either
pyrimethamine or sulphadiazine clearly suggested that genetic
recombination had generated these types. The proposed mechanism
lias been summarised in Fig. 8.
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FIG. 8













c ia is X
P"1 = pyrimethamine resistant allele
+ = wild type allele
iu — sulpiias.iiazine resistant allele
Trie reconstruction experiments summarised in Table 25
represented an attempt to estimate the frequency of class 1
recombinants (sulpbadiazine resistant) among the cross—product
blood parasites. Although this could have been done by scoring
large numbers of clones this would have been laborious in the
extreme considering the expected frequency of the type of clone
and the numbers needed to render the estimate statistically
significant. However following the PABA shift after Jan. 1975,
only this type of parasite could grow in the absence of a PABA
supplement thus allowing use to be made of the screening
technique.
On the face of it the results show that the infection of
1 and 10 parasite inocula of cross product parasites in mice
receiving no PABA supplement was consistent with the frequency
1 23
of PABA independent parasites being equal to 12.5fl. This
figure is the theoretical expectation given no linkage between
the two genes proposed to control resistance to pyrimethamine
and to sulpliaciiazine. However, given the conditions of the
cross it was possible for lines to grow at unequal rates so the
conclusion that there was no linkage between these two genes
must be accompanied by that caveat.
(in order to resolve such ambiguities and also to study
more precisely the genetic events following fertilisation, .it
was planned to extend the analysis of cross 4 by the character¬
isation of the products of single hybrid oocysts. As has been
stated elsewhere ( p* S7 ) this cross failed and it was thought
most likely that the reason for this failure was the poor
infectivity of pre-rupture oocysts. Following Vanderfoerg (1975)
it was reasoned that sporozoites harvested from these early
oocysts had not matured sufficiently to have developed full
infectivity in mice.)
Recent work in this laboratory has confirmed that pre—
rupture sporozoites in P,cfaabaudi are of low infectivity in mice
and further attempts are being made to improve the technique.
(Padua, pers. comm.)
Had the work been successful, it would have been possible
to look directly at single genetic events instead of by the
method of inference from scoring randomly selected clones from
among a mixed population of hybrid and parental oocysts. Further¬
more, as Y/aHiker et al., (1975) have pointed out such a study
might help in the more precise location of the meiotic reduction
division particularly in the light of the report that such a




Cross 5 (pp 88-91 ) may be considered the reverse of
cross 4 with the two non parental types generated among the
products of the latter used as parents in the former cross.
Although it would have been possible to use as parents these
actual recombinants themselves, it was decided to use the single
mutants they most resembled, AJ 7032 and AS ill 1)1?, in preference
since these had been studied in greater detail and their genetic
constitution better understood. The cross was conducted after
Jan. 1975.
Characterisation of the 14 cross product clones (Table 26)
revealed only three with non parental phenotypes. (One of these
CX51Q, was classified as non parental after retesting.) Again
all or none growth at restrictive PABA levels proved a more
informative diagnostic aid in identifying non parental clones
than did growth after pyrimethamine treatment. (in fact, the
— 1
lower pyrimethamine dose (4 x 1.25 rag,kg ) was probably too
low to completely distinguish sensitivities from non sensitivities
and had the cross been repeated a slightly higher dose, say
4 x 2.5 rag.kg~1, would have been used in preference.) However
MBA growth although most useful in distinguishing the non
parental clones did allow these to be classified into the two
types expected and in this case the pyrimethamine response data
were used.
Two of these three- presumptive non parental clones were
again tested and this time their quantitative responses to
pyrimethamine and sUlphadiazine estimated. These data have been
summarised in Table 27 along with comparison data for the
parents and the wild type ana double mutant lines with which
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last two lines it was proposed to identify the non parental
clones. Clone CX514 was classified as resembling the wild,
phenotype (EDCq pyrimethamine = 1.04 rag. kg' (+ IfcflB range
0.81 — 1.82 mg.kg ^)) and clone CX512 appeared to resemble the
double mutant AS 90801 (ill) pyrimethamine = 30.5 mg.kg * ( +yu —
ISil range 30.5 - 48.4 mg.kg ^, after retesting)) . These
diagnoses were supported by their respective responses to
sulphadiazine - both being within the range expected of wild
type and double mutant lines: (CX514 EDg^ sulphadiazine =•
55.3 mg.kg (+ ISE range = 38.1 — 80.4 mg.kg ) and CX512
EDgg sulphadiazine = 31.6 mg.kg ^ (+ ISE range = 15.1 - 66.1
nig• kg *) - both estimates obtained with the normal PABA
~ 1
supplement of 0.5 gl .))
Accepting this hypothesis that genetic recombination had
generated a wild type and a double mutant from two single mutant
parents we can visualise the cross thus: (Fig. 9}
FIG. 9
Cross between two singly resistant lines generating a double















F = pyrimethamine resistant allele
+ = wilu type allele
S*1 = sulphadiazine resistant allele
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The evidence from both crosses 4 and 5 demonstrate that
genetic recombination can readily take place in P.chabaucli
between these markers conferring resistance to sulph&diazine
and pyrimethamine respectively and there is no reason to
suppose that a similar process may not take place among human
malarias. It is perhaps interesting to note in this connection
that when 2 single step mutants resistant to pyrimethamine and
sulphadiazine respectively appear in combination whether as a
result of genetic recombination or following double selection,
their pyrimethamine resistance appears to sum geometrically.
Thus, for example (when measured at the ED„A level) while AJd0
7032 was estimated to be twofold cross resistant to pyrimethamine
and AS F DW was some 18 times resistant to this drug the figure
for the double mutant was estimated, to be 37—fold — almost their
exact multiple. However the errors in these compound indices of
resistance are of course considerable. Nevertheless if such a
geometric combination of resistance were shown to be a general
rule this would have serious implications in the field of human
malaria chemotherapy.
Although cross 6 ( pp.Q2-<?3 ) failed it has been reported
here since it was felt that the failure was not due to merely
technical causes. This cross was between two AJ lines: AJ 7032
which was sulphadiazine resistant; and AJ rat adapted which
could grow from clonal inocula in adult intact rats unlike the
other P.chabaudi lines described in this study.
Since the cross was conducted after Jan, 1975 the presence
of "PANA independent parasites among the products of the cross
was taken to show the transmission of the resistant parent. The
presence of parasites able to grow in intact rats was taken to
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demonstrate the transmission of the rat adapted parent.
The use of the double screening techniques was originally
intended merely to confirm the presence of recombinants and a
positive result i.e. parasites still present after growth in
rats receiving no PABA supplement would have required more
rigorous confirmation from clone characterisation, however the
negative result that was actually obtained did not necessarily
mean that recombination had not occurred. It was possible the
rat adaptation (which had been shown to be stable through •
mosquito passage) if due to genetic mutation might have been
polygenic in origin: the selection procedure used, repeated
passage through splenectomised and intact rats, was conducive
to the accumulation of ^soint mutations. Given this, recombin¬
ation might nave "diluted" these point mutations so that none
of the cross products which had the sulphodiazine resistance
mutation and were therefore able to grow in the absence of a
BABA supplement had sufficient of the rat growth point mutations
to survive the double selection. This model has been summarised
in Fig. 10. E.g. given a three point model for rat adaptation
only one in sixteen hybrid oocysts would have been expected to
generate recombinants capable of surviving double selection and
as the number of these point mutations increases so does the
rarity of detectable recombinants. In view of the rather low
fertility of the rat adapted line it was not unlikely that such
was the paucity of hybrid oocysts as to further reduce this
figure. Although a semi-in vitro test of rat adaptation was
attempted this was unsuccessful, tilth this test it had been
hoped to detect intermediate levels of rat adaptation. Clearly
recent improvements in the continuous culture of Plasmodia (Trager
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et al., 1976) offer hope in this field.
In addition to this explanation two other plausible theories
were considered. It was possible that the process of rat
adaptation had altered the mating preference of the gametes
produced by this line. Clearly a preference ior incestuous
Matings would correspondingly reduce the frequency of hybrid
oocysts,
d
Alternatively ijtose linkage between any of the series of
alleles conferring- rat adaptation and the allele conferring
sulphadiazine resistance would have reduced the frequency of rat
adapted PABA independent recombinants.
In conclusion the marker conferring rat adaptation was
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cleaned unsuitable for use either as a selective earlier or as an.
additional marker since its mode of inheritance remained,
unelucidated and -was possibly polygenic. In fact the phenomenon
of rat adaptation probably deserved, a separate study. In such a
study the line undergoing adaptation should ideally have been
cloned between selective rat passages and tested for changes in
rat growth ability along with controls.lines exhibiting such
changes could then have been analysed genetically. Such a
procedure would tend to minimise the chances of selecting poly—
genic mutants.
Clearly then the attempt to analyse rat adaptation
genetically illustrated the difficulty of handling polygenic
mutants in ignorance of the details of their selective Histories.
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Genetic mutctioas are widely believed to involve
alterations in the UNA of living orgonisjas. By the processes
of transcription and translation those mutations find, their
way into the amino acid sequences of the proteins or polypeptides
encoded. Many types of mutation have been discovered from
studies on micro—organisms: substitution of purine or
pyrimidine bases for one another; inversion of two or more bases
and deletions of one or more base. These base changes can vary
in effect from the total abolition of the function of that gene
following the manufacture of a grossly defective protein or
polypeptide chain -to small alterations appearing to have little
or no effect on the efficiency of the encoded enzyme such as
these cases of enzyme polymorphism in Plasmodia revealed by the
work of Carter (1970, 1871, 1973). (For reviews of these
mechanisms see v'/oese (1967} and Stahl (1969)).
Although technical constraints have made it impossible to
demonstrate these processes in plasmodia with anything approaching
the precision possible in other micro-organisms, notably certain
bacteria and viruses (reviewed by Hayes, 1969), some interesting
approaches at the molecular level have been made. In view of the
widely accepted "mapping" of genetic mutations onto enzymes the
report (Perone, 1969; Ferone et al., 1970) of differences between
dihydrofolate reductases in P.berghei sensitive and resistant to
pyrimethamine are strong supportive evidence that at least in
this case resistance had occurred as a result of mutations in the
UNA coding for this enzyme. Ferone1 s group found differences
both between the kinetics anu between the pyrimethamine inhibition
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co—eflicients of those enzymes. They had already shown (Ferone
e k a1-• > I'^Go) tuat pyrimethamine inhibited this enzyme 1000
times more in id bergaei than in the host mice.
The second type of evidence supporting the mutational
hypothesis concerns the stability of resistance to such drugs
as pyrimethamine and sulfadiazine. The few cases of unstable
resistance have been attributed to PuBA deficiency (Peters,
1970 ) to wuich we may add the reluctance of certain authors to
use cloned lines. In the present study, and in that by Morgan
(1974), no examples of loss of resistance following serial or
cyclical passages were observed. The suddenness and frequency
ox i esistance to antxfolates ana su 1 puouamxdo s arq both
consistent with the mutational hypothesis and in this respect
the experience of the present author was no different from those
of other authors (Young, 1957; Burgess and Young, 1959; Bishop,
1962; Biggens, 1970),
All the evidence of genetic studies (Walliker et al., 1971,
19i3, 1975; Morgan, 1974) has shown pyrimethamine'-resistance to
segregate as a single mendelian factor. This was confirmed in
the present study for both pyrimethamine and for sulfadiazine
resistance. Furthermore all of these examples of drug resistance
were obtained following single step selection which probably
favours the selection of single gene mutations.
Following on from this question it is reasonable to
enquire how closely did the estimated rates of acquisition of
resistance come to true mutation rates. We can probably ignore
estimates obtained from multi-passage experiments due to the
possibility of different mutations accumulating in successive
selective passages. We can also dismiss estimates obtained from
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single step selection experiments using short-term, high-dose
therapy since the rather high doses used in these probably kill
some resistant parasites as well as sensitives. Single step
drug selection experiments using continuous dose therapy while
an improvement in the latter respect could not have been
expected to guarantee very constant selection pressures during
the course of selection; variations would have resulted from the
mode of drug auministrabion and from the complication of the
host's speed of plasma clearance of the drug in question. (The
importance of a constant selection pressure is in maintaining:
conditions which ensure the survival of all resistant parasites
while at the same time favouring the elimination of sensitives.)
In the present study, these conditions were most completely
fulfilled in the PABA restriction experiment ticularly
those carried out after Jan. 1975 when the rat cake was assayed
to contain very little in the way of PABA related compounds.
It is reasonable to suppose that the host homeostatic mechanisms
would have maintained the parasites in a fairly constant PABA
environment.
This leaves a complication common to all types of selection
•particularly in the case of relapse techniques - the effect of
host immunity and its interaction with chemotherapy which if
significant would tend to lead to the underestimation of true
mutation rates. As to the significance of this immunity whether
passive or acquired we can only attempt a guess: the evidence
outlined in Table 9 that iatoaunosuppression hail no detectable
effect on the number of recrudescences observed afoer conoinuous
selection would seem to argue against the importance of immunity
although the evidence pointed the other way in the case of
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relapse selection (see ppl02-!02> ). However, we have no
independent measurement of the efficacy of this immunosuppression
other than one fact that normally mild lines of P. cliabau&i were
extremely virulent in mice receiving prednisone in their drinking
water. Thus, although there was no evidence of factors operating
which would have led to tlie serious underestimation of mutation
rates in the PjiBA restriction experiments certainity about this
was impossible.
The application of continuous culture techniques (Trager
et a1., 1976; Maynes et al., 1976) in selection experiments
should go a long way towards meeting many of the criticisms: it
should be possible to maintain constant selective conditions
semi—in vitro and the problem of acquired immunity should be
avoidable also.
A major assumption implicit in the equation of these
estimated rates of acquisition with true mutation rates is that
the resistant lines selected by any particular method arose as a
result of. mutation(s) in the same gene(s). The experiment in
which pairwise crosses between 3 independently acquired lines
resistant to pyrimethamine (cross 2) failed to detect
recombination between any of these lines suggests very tight
linkage. This added to the strong phenotypic resemblance noted
between all the pyrimethamine resistant lines obtained in the
present study (they were all accompanied by increased PABA
dependence) suggests mutation within the same gene.
In the case of sulphadiazine resistance the position was
much less clear. There seemed to be a spectrum of resistance
from that accompanied by no cross resistance to pyrimethamine to
that accompanied by a twofold or greater cross resistance. As
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has been noted the imprecision of the drug response estimates
may have accounteu for the failure to discern discrete levels of
cross resistance, however, tae ease with which sulphadiazine
resistance could be increased by superimposition without any
deoectable increase in the already enhanced cross resistance
suggests that at least two distinct classes of resistance existed
ana though no evidence was obtained regarding segregation between
these, there is no reason why this should not be tested.
In conclusion therefore although any estimate of the true
mutation rate is vitiated by the factors mentioned in the fore¬
going discussion it is believed tue acquisition rates obtained
in the course of the present work constitute the closest approach
yet to such an estimate in Plasmodia.
In view of the restriction of the present study to single
step selection experiments at a narrow range of drug doses under
defined levels of PABA supplementation it is not very
surprising that so few phenotypes were observed and although
there is no reason to suppose that a complete range of pheno—
types was detected (ana therefore a complete range of the genes
implicated in resistance to antifolates or sulphonamides) it is
worth pointing out that from these three proposed genes, no
less than seven phenotypes can be generated following their
combination in all the possible permutations. 6 of these
permutations were obtained in the present study ana the pheno—
types of these lines together with those expected on the basis
of the geometic summation of the resistances of each of the
single mutations proposed to have combined to form these double
ana triple mutants have been summarised in Table 2o.
1
TABLE 28
Gene combinations: observed and expected levels of resistance.
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^ s as estimated from PABA dependence
The point of all this is that given the fact of such
combinations arising via the superimposition of such single
mutations particularly following long term selection pressure,
a wide variety of types can be generated. This added to the
failure of most workers to use cloned lines and to control the
levels of PABA supplements (Peters, 1970 ) may help to account
for some of the wide range of resistance phenotypes reported in
the literature.
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The ease, demonstrated in the present study, with which
recombination occurred between markers conferring resistance to
pyrimethamine and to sulphadiazine has obvious significance in
understanding the ways in which resistance to these drugs is
spread. In this context the data of Eosario (1970a,b) merit
consideration: he showed that recombination occurred readily
between markers conferring resistance to pyrimethamine and to
chloroquine in P.chabaudi. However although this chloroquine
resistance was stable through unselected serial and cyclical
passage it was considered a low level resistance and after
further selection has been increased some 15-fold (Padua;
pers. comm.). Thus whether or not the earlier example of
chloroquine resistance was a suitable model for chloroquine
resistance in P.falciparum remains to be seen. It may transpire
that clinical examples of chloroquine resistance are inherited
by polygenic mechanisms.
The inheritance of drug resistance in bacteria has been
convincingly associated with cytoplasmic factors or episomes
(li'atanabe and Fukasawa, 1961; and V/atanabe, 1963); and while
erythromycin resistance in yeast (Thomas and Wilkie, 1963;
Cohen et al., 1970) and in parasitecium aurelia (Beale, 1969;
Eeale et al., 1972) have been shown to be inherited mitochondrially
no convincing examples of extrachromosoma1 inheritance have been
demonstrated in Plasmodia. The description by Yoeli et al.
(1969) of synpholia has -already been criticised on the grounds
that the technique used to detect drug resistance transfer
between P.vinckei and P.berg.hei was equally capable of inducing
resistance by selection (Biggens, reported in Peters, 1970 ).
Although Ferone et al., (1970) claimed the presence of a dihydro-
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folate reductase in the recipient P.berghei which was inter¬
mediate in character between that of the donor resistant
P.vinckei and that of a sensitive P.berghei was evidence in
favour of synpholia — it was surely even better evidence that
de novo selection had taken place.
Gene regulatory mechanisms in which the genes coding for
enzymes involved in successive steps in a biochemical pathway
are located together on the chromosome (co-ordinate induction)
are well known. The most famous example of such mechanisms.is
the lac operon in E.Coli (Jacob and Monod, 1961). Although both
antifolates and sulphonamides have been implicated in blocking
pyrimidine synthesis the absence of linkage between markers
conferring resistance to these drugs demonstrated in the present
study, argues against sucli a control mechanism in Plasmodia.
However the relevance of this pathway to the study of the
genetics of and mechanism of resistance to these drugs is obvious
and the pathway has been summarised in Fig. 12 (modified after
Jaffe and Guttsiidge, 1974).
It is believed that in Plasmodia de novo synthesis of
pyrimidines (from carbamy1phosphate and aspartate via orotate to
UMP) predominates over any salvage mechanism since pyrimidines
are only reluctantly incorporated into parasite UNA (Gutteri'dge
and Trigg, 1970). UUP seems to be freely interconvertible into
other pyrimidines and it is this conversion to dTMP which seems
to be affected by the action of sulphonamides and antifolates.
dUMP seems to be converted to dTHP by the action of an enzyme
first shown in P.loplmrae by Walsh and Sherman (1968) and in
P.chabaudi by Walter et a1. (1970) and by Walter and Konigk
(1971). This synthesis involves the transfer of a carbon group
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FIG „ 12
Pyrimidine synthesis and the sites of "action of •■pyrimethamine












liHSS = di'hydrofolate reductase





anu electrons from NrN,„ - methylene tetrahydrofolate to the 5O 1 w
position of dUMP with the concomitant oxidation of tetrahydro-
f olate to dihydrof olate. The reduction back to tetrahydrofolate
requires the enzyme dihydr ofolate reductase which seems to be
the prime target for the action of pyrimethamine (Ferone et al.,
1969). The transfer of a 1C group back onto tetrahydrofolate
from serine seems to be accomplished by serine hyciroxyraethy1
transferase (Platzer, 1972). Dihydrofolate the essential
co-factor required to maintain this cycle seems to be synthetised
de novo from GTP and the condensation of pteridines such as
PABA. A key enzyme in this pathway, dihydropteroate synthetase
has been isolated (Konigk and Walter, 1973). Mammals are able
to utilise preformed folates (unlike plasraodia) and the lack of
this pathway is the reason for the clinical effectiveness of
sulfonamides' in bacterial and malarial infections.
From consideration of this pathway it is possible to
construct ad hoc an explanation of the cross resistance patterns
observed in this study. If we accept that pyrimethamine
resistant lines contained altered dihydrofolate reductases then
the correlated hypersensitivity to sulfadiazine and increased
PABA dependence might have arisen as a result of such
alterations: the reduced affinity for pyrimethamine had required
some loss of the ensyme's efficiency in the conversion of FH^.
If the FHg pool size had been increased following PABA
supplementation the effects of this sacrifice might have been
minimised. On the other hand PABA restriction would have
exposed the enzyme deficiency in maintaining an adequate supply
of Pf.
Some mutations affecting the synthesis of IHg from the
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condensation of pteridines such as PABA are pictured in this
model as causing sulphadiazine resistance by increasing the
size of the Ml pool (for example following the breakdown of
IM<I
feedback inhibition resulting in an oversynthesis of enzyme or
by another mechanism). As well as causing sulphadiazine
resistance such a process would result in a small increase in
pyrimethamine resistance following the increase of the EHg pool.
Mutants which had caused sulphadiazine resistance without a
concomitant increase in the through-put of FII^ would not have
been expected to have been accompanied by a cross resistance to
pyrimethamine.
Proof of such speculations would depend upon accurately
measuring pool sizes of £TI0 and FS^ in sensitive parasites and
in those resistant to either pyrimethamine or sulphadiazine at
different levels of PABA supplementation and at different
concentrations of the two drugs. Although ideally such
experiments would require a true in vitro technique of parasite
cultivation using defined media - the recent availability of a
semi-in vitro technique (Trager et al., 1975} Uaynes et al.,
1976) offers some encouragement.
However perhaps the main stimulus to a genetic study of
malaria parasites offered by these techniques is the opportunity
they offer to study the genetics of drug resistance in human
Plasmodia particularly in the case of P.falciparum under
experimental conditions; and indeed, such a study is under
progress in this laboratory. After the initial technical
difficulties are overcome ^among these one might mention such
as that of transmission from semi-in vitro blood culture to
mosquitoes or that of measuring drug resistance ) the first
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task must be to repeat the pioneer work which has been under¬
taken using tiie rodent model. The main difference in approach
will be that as well as experimentally induced resistance
crossing experiments will have available lines whose resistance
has been acquired in the wild and not under controllea condition
Furthermore such "wild" resistant lines will also have unknown
genetic histories. Thus the problem will have additional
degrees of complexity.
This is not to say that experiments using the rodent model
are obsolete. The very fact that one can be sure rodent lines
have not been tampered with genetically disallows that notion.
Ifore positively the ready availability of a feasible technique
for the genetic study of rodent malaria parasites has generated
a momentum of its own ana several interesting lines of
investigation are open and it will be while yet before semi—in
vitro specialists catch up. Thus for example Rosurio (1976a,b)
demonstrated a case of mendelian inheritance of chloroquine
resistance in P.chabaudi. However this was at a low level (3
ag.kg~^) - about a twentieth that tolerated by the host. This
suggested two possibilities: either it was a basic genetic
building block of full chloroquine resistance; or it was an
adventitious example. Only continued research can provide the
answer.
Another example is provided in the present work by the
unsuccessful attempt to obtain infections from single oocysts
for cloning and characterisation. As well as confirming the
reciprocal mechanism^'inheritance of markers it had been hoped
this study would help in more precisely locating the stage of
the meiotic reduction division. Sinden and Canning (1973)
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reported cytological observations consistent with a reduction
division in oocysts of P.yoelii. Since the failure was possibly
technical in origin further investigations are merited.
It seems likely that particularly in the wake of chloroquine
resistant P.falciparum much effort will be employed in
developing suitable vaccines - thus allowing chloroquine to be
kept in reserve for acute cases once the vaccines have been shown
to be effective. Given this it will be important to extend the
genetic study of malaria to include the response of parasites to
immune mechanisms. It may be that as with Trypanosomas the
process of antigenic variation takes place (Grey, 1968/ and the
elucidation of its mode of inheritance would be the most
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